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INTRODUCTION
We are completing a study to determine the effects of suspension of rats in an
antiorthostatic, hypodynamic, hypokinetic model [1]. This model simulates some aspects of
weightlessness [1]. While not a perfect model, suspension studies can yield useful information
for planning of experiments for studies on astronauts actually undergoing space flight. Stress
factors in suspension can, in part, be controlled for by suspending rats in an orthostatic
position that does not result in effects similar to those of weightlessness [1]. Preliminary
studies we have carried out indicated that antiorthostatic suspension of rats and mice resulted
in a transient inhibition of interferon-alpha/beta production [2,3]. An additional study indicated
that such suspension of mice resulted in decreased resistance to encephalomyocarditis-D
virus, which correlated with the decreased interferon production [4]. The current grant
extended these studies in the following fashion:
1) Effects of suspension on interferon-gamma production,
2) Effects of suspension on interleukin-1 and interleukin-2 production,
3) Effects of suspension on distribution of leukocyte sub-populations,
4) Role of changes in calcium levels in initiating these effects, in an attempt to
determine the nature of the interactions of the immune system with other physiological
systems when suspension and space flight effects are induced.

METHODS, RESULTS AND DISCUSSION
3
The work that has been performed as part of this research grant has involved the study
of ground-based models for the effects of space flight on immune responses. The model for
which most time was spent was the antiorthostatic, hypokinetic, hypodynamic suspension
model for rats. From our results, it appears that suspension is useful for modeling the effects of
space flight on functional immune responses, such as interferon and interleukin production. It
does not appear to be useful for modeling shifts in leukocyte sub-populations. Calcium and
1,25-dihydroxyvitamin D 3 appear to play a pivitol role in regulating shifts in immune responses
due to suspension. The macrophage appears to be an important target cell for the effects of
suspension on immune responses.
Other studies were carried out to determine the role of various immunological
parameters in resistance to infection. Since we have shown that these parameters can be
altered after space flight and in the suspension modeling, it was important to determine the
role of these immune responses in resistance to infection, which could have impact in the
design of future flight and suspension studies to determine if the space-flight-induced
cganges in immune response actually alter resistance to infection. We shoewed that both the
classll histocompatibility antigens and the cytokines, which can be altered by space flight
and/or by suspension, played major roles in resistance to infection with microorganisms.
In addition, we have been carrying out collaborative studies with Drs. Felix Gmunder
and Augusto Cogoli to determine the role of the substratum in regulating the effects of
microgravity on lymphocyte activation. The results of this study indicate that the interaction of
lymphocytes with surfaces plays a central role in regulating lymphocyte activation.
In summary, we have successfully developed models for in vivo effects of space flight
on rat functional immune responses, and an _ model for functional human immune

4responses.
The detailsof this work aredescribedinpapersthat have beenpublishedas a result of
the work performed under this grant. The papers, creditingthe support from this grant, are
appendedto this report. In addition,we expect to publish additional manuscriptsbased on
thiswork in the future. Thesemanuscriptswill be forwardedto you assoon as they are ready.
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Depressed Interferon Gamma Production
and Monocyte HLA-DR Expression
After Severe In"gury
David H. Livingston, MD; Sarah H. Appel; Samuel R. Wellhausen, PhD;
Gerald Sonnenfeld, PhD; Hiram C. Polk, Jr, MD
• Monocyte HLA-DR antigen expression and mitogen-stim-
ulated Interferon gamma production were measured eequen-
tlally on days 1, 3, 7, 14, and 21 after admission in 20 multiply
Injured patients (mean Injury Severity Score, 33). Ten patients
recovered uneventfully and ten developed a major Infection,
three of whom died. Trauma resulted In Immediate and pro-
found depression of both Interferon gamma production end
monocyte HLA-DR antigen expression compared with con-
trois. Interferon gamma remained below control levels for all
days on which It was measured in all patients. In uninfected
patients, interferon gamma production began to recover after
day 7 and interferon gamma levels on day 21 were greater
than on all other days. Monocyte HLA-DR antigen expression
returned to normal between days 7 and 14 in uninfected
patients, despite subnormal production of interferon gamma.
Failure to increase interferon gamma production and mono-
cyte HLA-DR antigen expression was associated with an
episode of major infection. We postulate that stimulation of
the Immune system early after injury may reverse the defects
reported end decrease the incidence of infection after severe
trauma.
(Arch Surg 1988;123:1309-1312)
he recognition that the severely injured patient has an
increased susceptibility to infection has led investiga-
tors to examine the phenomenon of posttraumatic immune
depression as a potential cause2 _ Monocytes are involved
in multiple facets of cell-mediated immunity, including
antigen presentation, phagocytosis, killing of microorga-
nisms, cytokine production, and the induction of cytotoxic
effector cells. 5.' The ability to endocytose and process
antigens is an early and critical step in initiating an immune
response. 7 Expression of class II major histocompatibility
complex (MHC) antigens (HLA-DR and related antigens)
are thought to be required for monocytes to present an
antigen to lymphocytes and act as accessory cells. *"
Over 80% of circulating peripheral blood monocytes
constitutively express HLA-DR antigen on their cell sur-
face. =,s The sequential determination of the percent of
monocytes that express HLA-DR antigen has been dem-
onstrated to be a useful marker in following the immuno-
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logic recovery of patients after injury. = Three distinct
patterns of monocyte HLA-DR antigen expression were
seen after severe trauma that separated patients who
recovered uneventfully from patients who developed an
episode of major sepsis or died. = Modulation of HLA-DR
antigen expression is regulated, in part, by interferon
gamma and, therefore, differences in monocyte HLA-DR
antigen expression observed in the peripheral blood mono-
cytes of injured patients may represent differences in the
ability to synthesize interferon gamma. '2 Pure cultures of
monocytes lose their HLA-DR expression after incubation
but can be induced to reexpress this antigen by the addition
of exogenous interferon gamma for T cells. 's.'_ Trauma
patients who have low monocyte HLA-DR antigen expres-
sion will also increase such expression when their mono-
cytes are cultured in vitro with interferon gamma."
Interferon gamma is a glycoprotein produced by acti-
vated lymphocytes in response to antigenic or mitogenic
challenges and is a potent regulator of monocyte function. '_
Interferon gamma has been shown to enhance expression
of MHC class I and class II antigens on monocytes; the
production of the monokines interleukin 1 (IL-1), tumor
necrosis factor, and granulocyte-monocyte colony-stimulat-
ing factor; and monocyte-phagocytosis and bactericidal
capability. '7 Decreased interferon gamma production has
been reported after thermal and nonthermal injury2 .'_
In the present study, we investigated monocyte
HLA-DR expression and the production of interferon
gamma after admission to hospital in 20 multiply injured
patients. Correlations between interferon gamma produc-
tion and monocyte HLA-DR expression were examined,
with specific attention given to the relationship between
recovery of these factors and infectious morbidity.
PATIENTS AND METHODS
Patient Selection
Twenty multiply injured patients admitted to the University of
Louisville Trauma Service from July to December 1987 were
studied. There were 17 men and three women, with a mean age of
33 years (range, 16 to 74 years). Injuries included four gunshot
wounds, four burns, and 12 blunt injuries (ten motor vehicle
accidents, one fall, one airplane crash). The mean Injury Severity
Score (ISS) was 33 (range, 16 to 59). Patients were studied serially
on days 1, 3, 7, 14, and 21 after admission. All patients underwent
operation either immediately or soon after admission. The mean
number of operative procedures performed was 3.4 per patient
(range, one to ten). Each patient's hospital course was observed
for major infection, which was defined as bacteremia, intra-
abdominal, or intrathoracic infections that required operative or
percutaneous drainage, burn-wound infection, or pneumonia.
Depressed Interferon Gamma Production_Livingston et al 1309
fl
_4
Burn-wound infection was defined by the presence of greater than
10 _ organisms per gram of tissue on quantitative culture in the
presence of fever and leukocytosis, the histologic presence of
organisms invading normal skin on punch biopsy, or progressive
graft loss in the face of positive quantitative cultures. Pneumonia
was defined by positive sputum cultures for pathogenic organisms,
leukocytosis, fever, and the appearance of a new infiltrate on chest
roentgenogram.
Twenty healthy volunteers served as control subjects for the
determination of the normal range of interferon gamma production
and monocyte HLA-DR antigen expression.
Four patients undergoing minor operations (two rhinoplasties,
one chin augmentation, and one herniorrhaphy) were studied to
assess the effect of general anesthesia in patients with minimal
tissue trauma on HLA-DR antigen expression and interferon
gamma production. Blood was drawn for these studies just prior
to their operative procedure and 24 hours postoperatively.
Statistical analysis was done using a prior analysis of variance
followed by a Dunnetts, Tukey, or Student t test. (Significance
was set at P<.05.) This study was reviewed and approved by the
University of Louisville Human Studies Committee.
Interferon Gamma Production
Mitogen-stimulated interferon gamma was produced in cultures
of whole, unseparated blood, as described by Kirchner et al. _'
Venous blood was collected in tubes containing lithium heparin
(Beeton-Dickinson, Rutherford, NJ). The blood was diluted 1:10
with serum-free RPMI 1640 medium (GIBCO, Grand Island, NY)
supplemented with HEPES buffer (6 retool/L), tricene buffer
(3 mmol/L), gentamicin sulfate (50 mg/L), and glutamine salt
(2 mmol/L). One milliliter of the diluted blood was placed in plastic
tissue-culture tubes with 5 mg/L of phytohemagglvtimim-P
(Sigma, St Louis) and incubated at 37°C in 5% carbon dioxide for
24 hours. Following incubation, the supernatant was collected
after centrifugation and frozen at -70°C until assayed. The
interferon gamma level was measured in duplicate by a radioim-
munoassay (Centocor Inc, Malvern, Pa). This assay is specific for
interferon gamma alone and results are expressed in units of
interferon gamma per milliliter, based on the National Institutes
of Health (Bethesda, Md) reference standard for interferon
gamma.
Monocyte HLA-DR Expression
HLA-DR expression on peripheral blood monocytes was deter-
mined using fluorochrome-labeled monoclonal antibodies and flow
cytometry, as previously described. = Forty-microliter aliquots of
buffy coat cells prepared from acid-citrate-dextrose-anticoagu-
lated blood were stained for 20 minutes with the manufacturer's
specified dilution of antibody in the presence of 0.1% sodium
azide. Red blood cells were removed by hypotonic lysis and the
samples were preserved in 1% paraformaldehyde solution. Dual
staining was used in which monocytes were identified via the
labeled monoclonal antibody MO2 (Coulter Immunology, Hialeah,
Fla), and the HLA-DR antigen was identified via a second labeled
monoclonal antibody (Becton-Dickinson, Sunnyvale, Calif).
Samples were analyzed on a cytofiuoregraph IIS flow eytometer
(Ortho Diagnostic, Westwood, Calif) configured for simultaneous
two-color (red and green) fluorescent analysis. The forward-angled
and right-angled light-scattering properties of the leukocytes
enabled differentiation between lymphocytes, monocytes, and
neutrophils. The presence of HLA-DR was measured on mono-
cytes previously identified. A minimum of 200 monocytes were
analyzed for each sample. Results are expressed as the percent of
monocytes staining positive for HLA-DR.
RESULTS
Half of the patients studied developed an episode of
major infection. The sources of infection were the lungs in
seven, burn wound in three, thoracic and abdominal cavities
in two each, and major soft-tissue wounds in two. Six
patients had bacteremia, with organisms recovered from
another site of infection. Six of the ten patients had more
than one source of sepsis. The mean intensive care unit
and total hospital stays were 14 and 31 days, respectively.
The mean ISS was significantly greater in the infected
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patients compared with the noninfected patients (43 vs 25;
P<.05). Three patients died 30, 37, and 42 days, respec-
tively, after injury secondary to ongoing sepsis and multi-
ple-system organ failure.
The normal range for interferon gamma production was
28- + 13 _m/mL. General anesthesia without significant
tissue trauma was associated with minimal change in
interferon gamma production and monocyte HLA-DR ex-
pression. The mean preoperative value for interferon
gamma was 25 jxm/mL compared with the mean postoper-
ative value of 30 _m/mL.
Trauma had a profound and immediate effect on inter-
feron gamma production. In all injured patients, interferon
gamma levels remain below control levels for all days
studied (P<.05) (Table). In noninfected patients, interferon
gamma levels began to increase by day 14. Interferon
gamma production was significantly greater on day 21 than
on days 1, 3, 7, and 14 but remained well below that of the
controls. In infected patients, interferon gamma levels
were depressed markedly throughout the study period.
Inclusion of the three patients who died with the infected
patients did not significantly alter the pattern of interferon
gamma production.
The normal range for monocyte HLA-DR expression
was 89% - 4% and is comparable with previously reported
normal values. =.TMonocyte HLA-DR expression fell signif-
icantly after injury in both groups (Figure). Patients who
made an uneventful recovery exhibited return of HLA-DR
expression by day 14. In contrast, in patients who experi-
enced an episode of major infection, HLA-DR expression
never returned to normal. When the patients who died are
excluded, HLA-DR expression in the patients with major
infection increased only on day 21 compared with all
infected patients. This is similar to previously described
patterns of the recovery = of monocyte HLA-DR expression
and indicates that inclusion of the three patients who died
did not skew the results.
COMMENT
Monocytes express both class I (A, B, and C loci) and
class II (D locus) major histocompatibility antigens. Hu-
man MHC class II antigens are composed of DP, DR, DQ,
and DS subunits and are the equivalent of the immune-
response antigens (IA and IE) in the murine system. 5
Expression of MHC class II antigens is a necessary
condition for the monocyte to act as an accessory cell and
present antigen, although which specific subgroup or
groups of antigens are important remains unknown.*"
Gonwa et aP demonstrated that in a population of
HLA-DR-positive monocytes, cells that expressed
HLA-DS could present antigen and stimulate an autologous
mixed lymphocyte reaction better than HLA-DS-negative
cells. Expression of HLA-D antigens is a dynamic process,
and each subgroup has its own normal constitutive level of
expression. One study of freshly isolated human
monocytes demonstrated that HLA-DR, HLA-DQ, and
HLA-DP were expressed by 90%, 31%, and 19% of cells,
respectively. = Since HLA-DR is expressed with a greater
frequency than the other HLA-D antigens, down-regula-
tion and recovery of monocyte function may be best
assessed by changes in this antigen. The three patterns of
HLA-DR antigen recovery seen after injury in this study
demonstrate this hypothesis and explain why we chose to
measure this antigen. Monocyte cultures will lose their
HLA-DR antigen expression on incubation, which can be
restored by the addition of interferon gamma. Is,'' Inter-
feron gamma will also increase the expression of HLA-DQ
and HLA-DP antigens. _° Monocyte function, as measured
Depressed Interferon Gamma Production--Livingston et al
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Interferon Gamma Production by Day After Injury
Patient Groups 1 3 7 14 21
Noninfected 5.0 +_1.1 3.4 _+1.4 3.5 _+0.7 7.2 _-.3.01- 16.1 _+4.3_:
Infected (all patients) 2.1 _+0.8 1.4_+0.4 2.1 -+0.7 3.2 + 1.0 3.9_ + 1.4
Infected (survivors only) 1.2 _+0.3 0.9 -+ 0.4 2.1 -+ 1.2 3.3 + 1.6 5.1 +_2.7
*All valuesare mean -+SEM. Controlsproduced27.6 -+3.4 U/mL of interferongamma.
1-P<.05 vs infectedpatients.
:I:P<.05vs days 1,3, 5, 7, and 14.
100
o_ 90 _.._
_ 70
.L+ i /_-..d._ , /,,_t_
,1-
30 I I I I
1 3 7 14 21
Days After Injury
Monocyte HLA-DR expression measured sequentially after injury
in uninfected patients (circles), all infected patients (open triangles),
infected patients exclusive of the three patients who died (solid
triangles), and controls (shaded area). Values are mean of percent
HLA-DR-positive monocytes (_ SEM). Dagger indicates P<.05,
infected patients vs controls; asterisk, P<.05, infected patients vs
controls and uninfected patients.
by IL-1 production, declines simultaneously with HLA-
DR expression after overnight culture and can also be
restored by the addition of exogenous interferon gamma.='
The close relationship between monocyte function, as
measured by IL-1 production, and MHC class II expres-
sion, as measured by HLA-DR expression, is further
evidence that cell-surface antigen expression is an impor-
tant marker of the ability of monocytes to function as
accessory cells.Although the correlation between mono-
cyte MHC class II expression and the presentation of a
class II restricted antigen is far from simple, it is clear
that the lack of class II antigen expression indicates that
the monocyte is probably impaired in its abilityto act as
an antigen-presenting cell.
Interferon gamma has numerous functions other than
the regulation of cell-surface expression of MHC anti-
gens.'6,'_Endogenous production of interferon gamma has
been linked to protection from viral infection.Mice that
are resistant to herpes simplex type I virus demonstrate
elevated interferon gamma titerscompared with suscepti-
ble mice." The inabilityto produce interferon gamma may
reflectan increased susceptibilityto infection.Prophylactic
administration of interferon gamma has been shown to
decrease mortality from bacterial and protozoan infec-
tions. = Interferon gamma given even after bacterial con-
tamination decreased the incidence of wound infection after
hemorrhagic shock _ and increased the survival from gram-
negative infection after laparotomy. = The patients in this
series who developed a major infection had consistently
lower interferon gamma levels than those who made an
uneventful recovery.
Both interferon gamma and monocyte HLA-DR expres-
sion were measured by assays using whole blood. Previous
studies of monoeyte MHC class II expression have used
monocytes separated by adherence to glass or plastic. 8
These maneuvers select a subset of the monocyte popula-
tion or cause activation of the cells resulting in changes of
HLA-DR antigen expression. _ The use of flow cytometric
analysis allows for the study of freshly isolated monocytes
that are subjected to minimal handling and the ability to
count thousands of cells, which decrease any potential
sampling errors. Although the use of whole blood makes it
impossible to dissect the mechanism of interferon gamma
depression after injury, we feel that this disadvantage is
outweighed by the fact that the assays were done in a more
physiologic situation. Serum from trauma patients has
been suggested as a factor in immunosuppression _ and,
therefore, a whole-blood assay may be more clinically
relevant.
It is unknown whether prolonged depression of inter-
feron gamma production and HLA-DR antigen expression
causes an increased susceptibility to infection or if second-
ary infection after injury results in sustained depression
of the variables measured. Mean ISS, as previously re-
ported, was higher in the group of patients who had
pro|onged immune depression and who developed a major
infection. 8 Our data show that normal monoeyte HLA-DR
antigen expression returns between seven and ten days
after injury in uninfected patients. Return to normal
HLA-DR antigen expression was not predicated by the
ability to produce normal levels of interferon gamma in
culture, since the highest levels of interferon gamma
produced in infected patients in this series were signifi-
cantly lower than those of the controls. Small amounts of
interferon gamma can increase HLA-DR antigen expres-
sion on monocytes, and "subnormal" levels of interferon
gamma may be sufficient to return HLA-DR antigen levels
to normal. TM It is also recognized that regulation of mono-
cyte HLA-DR antigen expression is not regulated by
interferon gamma aIone. 1' The failure to increase monocyte
HLA-DR antigen expression to the normal range by day
14 was associated with an episode of major infection. Polk
and associates = demonstrated that recovery of monocyte
HLA-DR antigen expression in patients who made an
uneventful recovery was significantly different from that
in patients who developed major infection. Our study
confirms that finding and demonstrates that the recovery
of interferon gamma production also shows a difference
between infected and noninfected patients. Increased pro-
duction of interleukin 2 8 and colony-stimulating factor _
have also been demonstrated to occur earlier in patients
who experience an uneventful recovery after injury than
in patients who develop infections.
In conclusion, we have demonstrated that severe injury
results in an alteration of monoeyte HLA-DR antigen
expression and interferon gamma production. Rapid recov-
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ery of monocyte HLA-DR antigen expression was associ-
ated with an uneventful recovery. Although interferon
gamma production remained below control levels for all
periods studied, uninfected patients showed a parallel
recovery of interferon gamma production with monocyte
HLA-DR antigen expression. The failure to increase inter-
feron gamma production and monocyte HLA-DR antigen
expression was associated with an episode of major sepsis
or death. These data lend support to the concept that
stimulation of the immune system early after injury,
possibly with interferon gamma, may be beneficial and
decrease the incidence of infection after severe trauma.
This study was supported in part by grant NAG 9-181 from the National
Aeronautics and Space Administration, Washington, DC.
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Discussion
GEORGE W. MACHIEDO, MD, Newark, N J: In light of the
continued problems that we face in the clinical outcome of patients
with sepsis, particularly when septic shock or multiple-system
organ failure develops, it is necessary to investigate methods of
prophylaxis as well as treatment. As we enter the last decade of
the 20th century, it is evident that new antibiotics and improved
organ-support systems will not provide the answers. It is also
evident from the plethora of studies that have been presented at
this meeting on the function and dysfunction of the monocyte-
macrophage system that this cell line is assuming a central position
in the problems of sepsis. It follows logically, then, that attempting
to define these changes and modulate them is a promising
mechanism for therapy.
This article is one of a series by Dr Livingston and his associates
clarifying the changes that occur in interferon gamma levels and
in the expression of the HLA-DR antigen on monocytes following
trauma. They clearly showed an association between an impaired
return to normal parameters and the development of subsequent
infection; however, I think that the measure of that relationship
still needs to be defined.
Dr Livingston commented that patients who were subsequently
infected were more severely injured. Could he comment on the
incidence or level of hypotension, since we have recently reported
(Ann Surg 1988;207:549-554) a high incidence of early bacteremia
within the first hour or two following trauma in patients who were
admitted with blood pressures below 80 mm Hg? Why should he
not be looking at the effect of this early bacteremia rather than a
predicted cause? Has he looked at the data in a different way? In
other words, has he looked at it not by outcome, as he presented,
but by the actual interferon levels, with the percent of HLA-DR-
positive cells to determine, particularly with the interferon, that
there is a critical level above which no subsequent infection occurs?
KENNETH L. BRAYMAN, MD, Philadelphia: I would be interested
in knowing whether there was a difference in blood transfusion or
the initial septic insult in the patients who went on to suffer more
severe degrees of sepsis vs those who got better and whether
there was any particular value in relationship to HLA-DR expres-
sion of the monocytes.
We know that activated T cells are the ones thought to produce
interferon gamma, which in turn stimulates the macrophage
HLA-DR expression, and I was wondering whether you looked at
HLA-DR expression on T cells relative to other data.
DR LIVINGSTON: I will answer the questions in reverse order.
We did look at the impact of blood transfusions in this study and
it appeared that the volume of blood transfusions really made no
difference, ie, there was no difference among the groups. We do
recognize that T cells do express HLA-DR antigens; however,
their influence on interferon gamma production is not known at
this time. It may be interesting to look at that in the future.
Dr Machiedo recognized the fact that perhaps the more severely
injured patients did, in fact, get infected; however, the group as a
whole was fairly injured. The levels of initial contamination from
the outside were equal. We do recognize that bacterial transloca-
tion occurs most often in the more severely injured patients, and
I really cannot comment about the possible theoretical basis of
the increased levels of internal contamination.
The critical levels of endogenous interferon gamma production
is unknown, and we did not try to answer that question, although
it is interesting. How much interferon gamma is sufficient? It was
interesting to us that HLA-DR expression returned to normal
long before interferon gamma production was normal. It appeared
that the body could definitely regulate these cell-surface antigens
while producing very small amounts of interferon gamma, as
observed in culture.
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Effects of Interferon-7 and Tumor Necrosis
Factor-c on Macrophage Enzyme Levels
SILVIA S. PIERANGELI and GERALD SONNENFELD
ABSTRACT
Murine peritoneal macrophages were treated with interferon- 7 (IFN-7) or tumor necrosis
factor-c_ (TNF). Measurements of changes in acid phosphatase and _-glucuronidase
levels were made as an indication of activation by cytokine treatment. IFN-7 or TNF--y
treatment resulted in a significant increase in the activities of both enzymes measured in
the cell lysates. This increase was observable after 6 h of incubation, but reached its max-
imum level after 24 h of incubation. The effect of the treatment of the cells with both
cytokines together was additive. No synergistic effect of addition of both cytokines on
the enzyme levels was observed.
INTRODUCTION
NTERVERONS (IFNs) ARE NATURALLY OCCURRING PROTEINS whose originally recognized function
was antiviral activity. _'_ However, considerable evidence has accumulated for a broader biologi-
cal role for IFNs. This includes: inhibition of proliferation of normal and malignant cells/TM en-
hancement of numerous macrophage functions including phagocytosis _'' and nonspecific tumorici-
dal activity, augmentation of natural killer cell activity/_ antiproliferative and immunomodulatory
activities, _6''_ and inhibition of multiplication of nonviral intracellular parasites. _8-''_
Another cytokine of interest is tumor necrosis factor-_ (TNF). TNF was recognized by Carswell
et al. c,2_ in 1975. It is characterized by its ability to produce hemorrhagic necrosis of certain mouse
transplanted sarcomas in vivo and has cytostatic/cytotoxic effects on mouse and human tumor cells
in vitro._'_-'6_ In addition, sera containing TNF have been reported to inactivate certain species of
malaria parasites in vitro and to protect mice against Klebsiella pneurnoniae and Listeria rnonocyto-
genes. _17_ Lately it has been demonstrated that TNF inhibits intracellular multiplication of Try-
panosoma brucei in rouTine peritoneal macrophages. _s_ TNF can also act as an immunomodulator
because it increases the cytotoxic and phagocytic activities of polymorphonuclear cells. _,9_ TNF and
IFN-7 have been shown to act in a synergistic fashion in some cases. A strong synergistic interac-
Department of Microbiology and Immunology and Department of Oral Health, Schools of Medicine and
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tionbetweenbothcytokineshasalsobeenfoundwhentheircytotoxicactivitywasmeasuredoncer-
vical,breast,andovariancarcinomacelllines._2°-2'_
ThisstudywasdesignedtodeterminetheeffectsofIFN-_,andTNF treatment on levels of activ-
ity of acid phosphatase and #-glucuronidase in murine peritoneal macrophages. These enzymes can
serve as markers of macrophage activation. Czs_
MATERIALS AND METHODS
Preparation of Mouse Peritoneal Macrophages: Four- to six-week-old C57BI/6J mice were ob-
tained from Jackson Laboratories (Bar Harbor, ME). Mice were maintained in an AAALAC-ac-
credited facility according to NIH guidelines under the direct supervision of a veterinarian. The ab-
domen of each animal was thoroughly swabbed with alcohol and the skin deflected so as to expose
fully the peritoneal wall. The peritoneum was lavaged by injection of 5 ml of sterile RPMI 1640 me-
dium (GIBCO Labs, Grand Island, NY), supplemented with 10% heat-inactivated fetal bovine
serum (GIBCO), 100 IU/ml penicillin, and 100 _g/ml streptomycin. After gentle abdominal mas-
sage, the peritoneal fluids were collected aseptically. _ The cells were washed three times with me-
dium for 10 min, and resuspended in the same medium. The nucleated cells were counted micro-
scopically by using an hemacytometer and were adjusted to 10 viable celis/ml. Viability was assayed
by the trypan blue dye exclusion test. Aliquots (0.8 ml) were placed in Lab-tek tissue culture cham-
ber (Becton-Dickinson, Inc., Oxnard, CA) and incubated for 24 h at 37°C in 5% CO2. Nonadher-
ent ceils were then removed by flushing the culture chambers vigorously with fresh medium several
times.
Lysis of Macrophages: The cell monolayers were treated for 10 min with 0.8 ml of 0.1% Triton-
XI00 (Sigma Chemical Co., St. Louis, MO) in 0.05 M HCI and 0.15 M NaCI. ¢27_
Cytokines: Murine IFN-._, produced by recombinant DNA technology, was a gift of Genentech,
Inc. (South San Francisco, CA), and supplied at a specific activity of 0.68 x 10 _ U/mg of protein.
A stock solution was made in culture medium containing 1,000 U/ml. Dilutions were made up im-
mediately before use in the experiments (30, 100, and 1,000 U/ml). Human TNF, produced by re-
combinant DNA technology, was also kindly provided by Genentech, Inc. South San Francisco,
CA) at a specific activity of 5.02 × 10 _ U/mg of protein). A stock solution of 10,000 U/ml was
made in culture medium and kept in the refrigerator until use. Solutions of 30, 100, and 1,000 U/
ml were prepared immediately before use. Both IFN-'r and TNF were assayed for endotoxin by As-
sociates of Cape Cod, Inc. (Woods Hole, MA) and no inhibition was observed.
Enzymatic Assays." Acid phosphatase (E.C. 3.1.3.2.) and B-glucuronidase (E.C. 3.2.1.31) were
assayed in lysates using commercially available kits from Sigma Chemical Co. (St. Louis, MO).
Acid phosphatase was expressed in IU/liter and _-glucuronidase in modified U/ml.
General Assay Procedure: After 24 h of incubation in the plastic plates, nonadherent cells were
removed by flushing the plates vigorously. At this point the cells were ready for use. The macro-
phages were then incubated for 6 or 24 h with medium or with cytokines in three different concen-
trations, either alone or together or with the supernatant from the absorption with specific anti-
body anti-iFN. After this incubation at 37°C 5% CO2, the cells were washed twice with medium
and once with sterile phosphate-buffered saline (PBS) and lysed as described previously. Lysates
were frozen at -70°C until the enzymatic assays were done.
Neutralization of 1FN--r with Monoclonal Antibody against 1FN-,y: Monoclonal antibody was
obtained from the hybridoma cell line R4-6A2, kindly provided by Dr. Edward E. Havell (Tru-
deau Institute, Inc., Saranac Lake, NY).C2"_ Hybridoma cells were cultured in minimal essential me-
2
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dium (GIBCO Labs, Grand Island, NY), supplemented with 1007o fetal bovine serum, antibiotics,
glutamine, and 1 mM sodium pyruvate in a 707o COL atmosphere. Supernatants from culture were
concentrated to 15 mg/ml, determined by spectrophotometric readings. The antibody was dialyzed
exhaustively in phosphate buffer (0.2 M, pH 7.6). The following standard immunoadsorbent proce-
dure was used for inactivation of IFN-_/. _29J The antibody was polymerized with glutaraldehyde
(Sigma Chemical Co., St. Louis, MO) in a proportion protein/glutaraldehyde of 1:5. After 24 h the
gel was broken in a tissue homogeneizer and washed exhaustively. The broken gel was then incu-
bated with continuous rotation for 24 h at 4°C with an equal volume of IFN-y at a concentration
of 30 U/ml. The mixture was centrifuged at 3,000 rpm for 10 min and the supernatant was kept at
4°C and then assayed for IFN- T activity. _29_
Statistics: The results were subjected to Student's t test to determine whether or not there was a
significant difference between the averages of enzymatic determinations with cytokines and the
controls. _26_ Alpha was set a priori at p < 0.05.
RESULTS
Effect of the treatment of mouse peritoneal macrophages with IFN-T on the
activities of [3-glucuronidase and acid phosphatase in lysates
Mouse peritoneal macrophages were treated with different concentrations of IFN--_ (30, 100, and
1,000 U/ml), and after 24 h of incubation they were washed and treated with medium, according to
procedure described in Materials and Methods, The enzymatic activities were measured in lysates
(Table 1). When IFN--y-treated cells were compared with medium-treated cells, there was an in-
crease of 4.4-, 5.7-, and 7.1-fold in the activity of _-glucuronidase for 30, 100, and 1,000 U/ml, re-
spectively. When acid phosphatase was measured, cells treated with IFN-7 showed an increase of
2.5-, 2.6-, and 2.8-fold over the cells treated only with medium.
Effect of the treatment of murine peritoneal macrophages with TNF on the
activities of (3-glucuronidase and acid phosphatase in cell lysates
In this case, cells were treated with three different concentrations of TNF, 30, 100, and 1,000
U/ml, as described in Materials and Methods. Enzymatic activities were determined in lysates
(Table 2). When cells treated with TNF were compared with cells treated with medium, there was
an enhancement of B-glucuronidase activity of 4.5-, 5.6-, and 5.4-fold for 30, 100, and 1,000 U/ml
of TNF, respectively. TNF-treated cells showed an increase of 1.6-, 2.0-, and 1.5-fold increase in
the activity of acid phosphatase, when compared with medium-treated cells, at the three different
concentrations mentioned above.
TABLE 1. EFFECT OF THE TREATMENT OF MOUSE PERITONEAL MACROPHAGES WITH
IFN-_¢ ON THE ACTIVITY OF /3-GLucURONIDASE AND ACID PHOSPHATASE a
f3-Glucuronidase activity Acid phosphatase activity
Treatment (U/mO (IU/fiter)
Medium 12.7 + 2.2 0.70 + 0.06
IFN-_ 30 U/ml 70.5 _ 5.6b 1.75 ± 0.10 b
IFN-T 100 U/ml 72.7 + 5.2 b 1.79 ± 0.lib
IFN--,/ 1,000 U/ml 90.2 + 2.7b 1.89 :t= 0.03 b
aResults are expressed as the mean of five experiments _: standard error of the mean.
bp < 0.05.
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TABLE2. EFFECT OF TREATMENT OF MOUSE PERITONEAL MACROPHAGES WITH TNF
ON THE ACTIVITY OF fl-GLucURONIDASE AND ACID PHOSPHATASE IN CELL LYSATES a
13-Glucuronidase activity Acid phosphatase activity
Treatment (U/mO (IU/liter)
Medium 15.75 4- 3.7 0.68 ± 0.16
TNF 30 U/ml 70.50 4- 1.5 b 1.11 ± 0.19b
TNF 100 U/ml 88.50 4- 1.5 b 1.37 ± 0.33 b
TNF 1,000 U/ml 85.50 4- 1.6 b 1.02 4- 0.02b
aResults are expressed as the mean of five experiments ± standard error of the mean.
bp < 0.05.
Effect of combined treatment of mouse peritoneal macrophages with IFN-7 and
TNF on the activities of fl-glucuronidase and acid phosphatase
Murine peritoneal macrophages were treated with medium or with a mixture of both cytokines at
final concentrations of 30, 100, and 1,000 U/ml of each cytokine for 24 h. The enzymatic activities
were determined in lysates (Table 3). Macrophages treated with both cytokines at the three differ-
ent concentrations showed a pattern of increase in fl-glucuronidase of 8.2-, 10.7-, and 13.0-fold.
When acid phosphatase was measured in iysates, cells treated with both cytokines simultaneously,
the enhancement was 4.1-, 4.2-, and 4.4-fold at concentrations of each cytokine of 30, 100, and
1,000 U/ml.
Effect of anti-IFN-7 on the enhancement of activities of fl-glucuronidase
and acid phosphatase induced by IFN-_¢
IFN-3, was mixed with anti-IFN-,/, and then cells were treated with antibody-neutralized-IFN or
with medium and/or TNF (30 U/ml) for 24 h. The enzymatic activities were analyzed in lysates
(Table 4). In both experiments enhancement of fl-glucuronidase and acid phosphatase by IFN-3,
was abrogated totally by antibody treatment. Furthermore, cells treated with TNF retained the en-
zyme activation that was due to TNF. Effect of time of incubation of cytokines on the activity of
fl-glucuronidase in mouse peritoneal macrophages.
Macrophages were incubated with IFN-'r or TNF for 6 or 24 h, and then washed and lysed for
enzymatic analysis. At 6 h, the activity of B-glucuronidase induced by 1FN- 7 was loser in all sam-
ples than in the corresponding sample at 24 h of incubation (Fig. I). After 6 h of treatment with
TNF the values were 80-90% of the ones obtained with 24 h of incubation (Fig. 1).
TABLE 3. EFFECT OF COMBINED TREATMENT OF MOUSE PERITONEAL MACROPHAGES WITH IFN-3' AND
TNF ON THE ACTIVITY OF fJ-GLucURONIDASE AND ACID PHOSPHATASE IN LYSATES a
fl-Glucuronidase activity Acid phosphatase activity
Treatment (U/ml) (IU/liter)
Medium
IFN 30 units + TNF 30 units
IFN 100 units + TNF 100 units
1FN 1,000 units + TNF 1,000 units
15.75 + 3.8 0.68 4- 0.16
129.00 4- 30.0 b 2.99 4- 0.43 b
168.00 4- 22.5 b 2.90 4- 0.20b
206.25 + 36.6b 2.14 ± 0.36 b
aResults are expressed as the mean of five experiments a: standard error of the mean.
bp < 0.05.
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TABLE 4. EFFECT OF INACTIVATION OF IFN-7 BY TREATMENT WITH ANTI-IFN-7 ON THE ACTIVITY OF
_-GLucURONIDASE AND ACID PHOSPHATASE IN LYSATES OF Mouse PERITONEAL MACROPHAGES a
_-Glucuronidase Acid phosphatase
Treatment activity (U/mO activity (IU/liter)
Medium
IFN-7 30 units + anti-IFN--_
IFN-? 30 units + anti-lFN-? + TNF 30 units
15.75 + 3.7 0.84 + 0.03
12.75 _: 2.2 0.85 ± 0.09
56.50 -_ 6.5 b 1.44 ± 0.30b
aResults are expressed as the mean of five experiments _: standard error of the mean.
bp < 0.05.
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FIG. 1. Effect of time of incubation with IFN-.,/and TNF on the activity of/3-glucuronidase in
lysates of mouse peritoneal macrophages. Treatment A, IFN-? 30 U/ml (6 h); treatment B, IFN-3,
30 U/ml (24 h); treatment C, TNF 30 U/ml (6 h); treatment D, TNF 30 U/ml (24 h); treatment E,
medium.
Effect of time of incubation of cytokines on the activity of acid phosphatase in lysates
Macrophages were incubated with IFN-3, or TNF for 6 or 24 h followed by washing and lysis.
Acid phosphatase activity was tested in lysates. When IFN-_/was used as the stimulating cytokine,
the values obtained at 6 h of incubation were lower (40-60%) than the ones obtained with 24 h of
incubation (Fig. 2). With TNF, there was no difference between 6 h and 24 h of incubation (Fig. 2).
DISCUSSION
Activated macrophages possess properties exceeding, qualitatively or quantitatively, the baseline
values exhibited by resident macrophages. Although there seem to be a variety of biochemical cri-
teria to describe the state of activation in mouse peritoneal macrophages, several parameters have
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FIG. 2. Effect of time of incubation with IFN-3, and TNF on the activity of acid phosphatase in
lysates of mouse peritoneal macrophages. Treatment A, IFN-y 30 U/ml (6 h); treatment B, IFN-y
30 U/ml (24 h); treatment C, TNF 30 U/ml (6 h); treatment D, TNF 30 U/ml (24 h); treatment E,
medium.
been used to describe this particular status. These include enzyme synthesis and secretion, as well as
functional capacities. C3'_
In the present study, the enhancement of the activity of two macrophage hydrolases by cytokine
treatment was used as a method to determine the in vitro activation of such cells. IFN-y or TNF
treatment produced a significant increase in levels of/3-glucuronidase and acid phosphatase. Fur-
thermore, a dose of 100 U/ml of TNF appeared to be most effective in raising enzyme levels. This
dose could have been most effective due to a cytotoxic effect of TNF at higher concentrations.
It has been demonstrated that lipopolysaccharide (LPS) by itself is a potent stimulator of macro-
phages. _32_LPS can be present in some preparations of recombinant cytokines as a product of the
DNA technology, when the gene is cloned in bacteria. However, the possibility of LPS playing a
role in the present study was minimized, as the activity of the IFN was completely abrogated by
treatment with specific monoclonal antibody, and the IFN-y and TNF preparations appeared to be
free of LPS. Control experiments were carried out with the same batches of medium in which the
cytokines were prepared. These results suggest that the activity observed was due to IFN-y, and not
LPS.
Macrophages treated for 6 h with IFN-,,/were activated up to 40-60°70 of maximum for/3-glucu-
ronidase and acid phosphatase production. However, maximum effect was not observed until 24 h
of incubation. Morland et aL have demonstrated similar results, and they also found that pro-
longed treatment for 48-72 h could produce a decrease in the enzymatic levels.(25) However, in the
present study when the cells were incubated with TNF, maximum acid phosphatase activity and
80% of the maximum _-glucuronidase activity was reached by 6 h of incubation. Therefore, it is
possible that each cytokine may utilize a different mechanism of activation.
It is becoming apparent that both IFN-,), and TNF have a complex pattern of interaction. Several
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synergisticinteractionsbetweenIFN-yandTNFhavebeenreported.Forexample,theBI6mela-
nomacellineisnotsensitivetoTNFunlessit isappliedincombinationwithIFN-y._3_Synergistic
effectsbetweenbothcytokineshavebeendescribedregardingtheantiproliferativeresponsein vivo
and in vitro systems, and in the production of Class I and Class II histocompatibility antigens.C3"_
The molecular mechanism of the synergistic effect is not well understood. However, some investi-
gators _3_ have demonstrated that in several target cell types, short-term inhibition of target cell
protein or energy metabolism caused a highly accelerated cytolisis. It has also been postulated _'_
that IFN-3, renders target cells more sensitive to TNF lysis by some form of alteration in the cell
membrane structure, perhaps through the exposure of a TNF-binding receptor. In the present
study, the effect of incubation of both cytokines together was additive rather than synergistic re-
garding the enzymatic activities in the lysates. Although the use of additional cytokine concentra-
tions could possibly yield different results, the present data suggest that a generalization that TNF
and IFN-y will act synergistically in all systems cannot be made. This is supported by the recent ob-
servation that TNF is associated with macrophage killing of Mycobacterium avium complex, but
that IFN- 7 plays no role in this act. c37_
It should be noted that the TNF available to be used in this study was human. We chose to use
the human TNF and routine IFN-y because the bulk of studies showing synergy have used this
combination.C'9'_°'33 J,_ Even though human TNF is cross-reactive in mouse cells, it is still a foreign
protein and it is possible that different results could be obtained using murine TNF in the system
used in the present study.
The results of the present study indicate that both IFN-y and TNF can activate macrophages as
indicated by enhancement of _-glucuronidase and acid phosphatase activities. The significance of
this activation and possible interactions between IFN-7 and TNF in an in vivo model of infection
remains to be established.
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ABSTRACT
Interferons have been shown to be involved in several non-viral, microbial infections.
These include both protozoan parasite and bacterial infections. Interferons have been
shown to be induced during those infections and to alter the course of the infections.
The mechanism for the effects of interferons on non-viral microbial infections may
involve the modulation of immune responses. Many different types of immune responses
can be affected by interferons, and this may affect host defenses against microbial
infections. Many exciting research areas are developing for the study of this intriguing
property of interferons.
INTRODUCTION
Interferons (IFNs) were described originally as antivirals (1). However. in recent
years it has become clear that IFNs can affect the outcome of several different non-
viral microbial pathogens. Recent studies have shown that IFNs have several activities
in addition to the antiviral activity, and it is possible that these additional activities
could contribute to the anti-microbial effects of IFNs. One of the most significant of
those activities is modulation of immune responses (2). As natural IFNs have been purified
and pure IFNs have been produced by recombinant DNA technology, it has become
apparent that the IFNs themselves are responsible for the immunomodulatory activities
that have been observed (2). As a result of its immunomodulatory properties. IFNs could
play major roles in resistance to various microbial infections.
TABLE 1 TYPES OF INTERFERONS
IFN-ALPHA leukocyte type I
IFN-BETA fibroblast type I
IFN-GAMMA immune type II
It is now clear that all three types of IFNs (IFN-alpha, IFN-beta. and IFN-gamma)
have immunomodulatory properties (Table 1). IFN-alpha is produced primarily by
lymphocytes in response to viruses, double-stranded RNAs. lipopolysaccharide and other
non-specific inducers (3). Several sub-species of IFN-alpha have been shown to exist
as a results of cloning of the genes (3). IFN-beta is produced by _fi_;)z.ob_sts in response
to the same types of inducers as IFN-alpha (3). In rodents, it is difficult to separate
these two types of IFN,and they are often referred to as IFN-alpha/beta. The third
type of IFN, IFN-gamma, is an actual product of cell-mediated immune responses.
IFN-gamma is produced by sensitizedT-lymphocytes in response to specific antigen.
or by T-lymphocytes in response to a mitogen such as phytohemagglutinin or con-
canavalin-A(3). These IFNsdiffer from each other with regardto antigenicity, structure,
and the genetic information coding for the proteins (3).
The IFNs have all been shown to have a variety of immunomodulatoryactivities
(Table 2). In both humanand animalmodels.IFNshavebeenshown to modulateantibody
production(4. 5). When IFN-alpha/betaor inducersof IFN-alpha/beta were administered
to mice at the time of or prior to sensitizationof the mice with sheepred blood cells,
the plaque forming cell responsewas suppressed(6-15). This type of responsewas
found to occur both in vitro and in vivo. and when the dose of IFN- alpha/ beta was
reduced or when IFN was administered after sensitization with antigen, antibody production
was enhanced (7-9). Similar results were observed using human in vitro systems (16,
17). Therefore, IFN- alpha/ beta had a time and dosage dependent effect on antibody
production. This would suggest a truly immunoregulatory role for IFNs, as the same
substance in the same system can enhance or suppress an immune response.
TABLE 2 IMMUNOMODULATORY ACTIVITIES OF INTERFERONS
1. Modulation of antibody production
2. Modulation of delayed hypersensitivity/cell- mediated immunity'
3. Regulation of cell surface antigen expression
4. Activation of Natural Killer cells
5. Activation of macrophages
6. Interaction with other cytokines
(interleukin- 2. tumor necrosis factor)
Similar results were observed using IFN-gamma or inducers of IFN-gamma (18-
20). In the case of IFN-gamma, much smaller doses of IFN-gamma were required to
observe the same effects as with IFN- alpha/ beta. suggesting that IFN-gamma might
be a more potent immunoregulatory agent. Modulation of antibody responses by IFN
-gamma was also time and dosage dependent in a similar fashion to what has been
reported for IFN- alpha/ beta (18-20). B cells might have been affected directly by
the IFN-gamma preparation (20).
IFNs can also affect the cell-mediated immune response. Administration of IFN-
alpha/beta resulted in an inhibited delayed hypersensitivity response to sheep red blood
cells in mice (21).
In addition, IFNs have been shown to play a crucial role in regulation of the response
of natural killer cells (22-28) in humans and rodents (Table 2). Natural killer cells
are naturally cytotoxic to infected or tumor cells. The presence of IFNs augments
dramatically the activity of natural killer cells (22-28). IFNs-alpha and -beta may be
most effective in activating natural killer cells. It should be noted that treatment of
tumor target cells with IFN results in protection of those cells from natural killer cells
(22). This is additional evidence for a natural immunoregulatoryrole for IFN where
presenceof the IFN at a specific time and placeduring the developmentof an immune
response could result in a differing end result.
IFNs have also been shown to regulate macrophageactivation (29-35). All IFNs
have been shown to be able to regulate macrophageactivation in rodent and human
systems,but IFN-gammaappears to be most effective in activating macrophages.The
activation appears to result in enhanced phagocytosis,and in some cases,enhanced
killing of tumors or microbial pathogens (29-35).
There are several possible mechanisms for modulation of immune responses by
IFNs.There can be direct effects of IFNs on cells, or interactions of IFNs with other
cytokines.
IFNs could affect directly the maturation, activation and development of cells
important in immune responses. As stated above. IFNs can regulate the maturation
of B cells, thereby resulting in the regulation of antibody responses(36).
One of the most fascinating potential mechanismsfor IFNs to regulate immune
responses is through the expression of cell surface antigens (Table 2). In a series
of experiments first carried out by Gresser and his associates(37-41), IFN-alpha/
beta was shown to be able to enhanceexpressionof class [ histocompatibilityantigens
on the surface of cells. Later, IFN-gamma was shown to have a similar effect (42).
Regulationof expressionof class | histocompatibilityantigenscould affect the efficiency
by which cytotoxic T-lymphocytes interact with targets such as tumor cells or infected
cells. IFNscan also modulatelevelsof expressionof Fc receptorson cells(43). Alterations
in these receptors could affect the ability of a host to mount several immuneresponses
involving these receptors such as allergic responsesinvolving IgE.
IFN-gammacan also regulate the expressionof class ][ histocompatibilityantigens
on a variety of cell types (42, 44-48). The class ]] histocompatibility antigens play
a fundamental role in foreign antigen presentation from macrophagesto lymphocytes.
Therefore,the ability of IFN-gammato regulatetheir level could result in a fundamental
immunoregulatory role for IFN in a wide variety of immune responses.
In addition IFNs have been shown to interact and regulate production of a wide
variety of other cytokines.These include interleukin-2 and tumor necrosis factor-alpha
(49-51). As a result of this interaction, IFNs could play a major role in the regulation
of immune responses by regulating the duration and extent of such responses.
It is. therefore, possible that IFNs could be major regulators of native immune
responsesin a host. If IFNsdo play such a natural role. then it is possible that IFNs
could regulate resistanceto infection with a wide varietyof pathogens.Thesepathogens
could include a range of organismsfar beyondthe viruses for which IFNswere originally
thought to be active. I shall now describeexperimentsusing mouse modelsof infection
carried out in conjunction with my laboratory to explore the role of IFNs in resistance
to protozoan parasite and bacterial infections (Table 3).
TABLE3 MICROBIALINFECTIONSAFFECTEDBY INTERFERONS
STUDIEDIN THE AUTHOR'SLABORATORY
BACTERIAL :
Salmonella typhimurium
Eschedchia coli
Staphylococcus aureus
Klebsiella pneumoniae
PARASITIC :
Trypanosoma cruzi
Trypanosoma brucei
Naegleria fowled
INTERFERONS AND MICROBIAL INFECTIONS
Studies in my laboratory have been directed towards two protozoan parasites,
Trypanosoma cruzi, the intracellular South American trypanosome, and Trypanosoma brucei
rhodesiense, an extracellular African trypanosome. IFNs appear to be able to be involved
in the course of both the intracellular and extracellular infections.
T. cruzi is the cause of Chagas' disease, and early reports indicated that a substance
similar to IFN was induced during the course of infection of mice (52. 53). We were
able to show that mice infected with T. cruzi actually did produce IFN-alpha/beta during
the early stage of infection (54. 55). Others showed that interferon-gamma was produced
late in the course of infection (56). Mice treated with IFN-alpha/beta beginning at
the day of infection showed a transient decrease in parasitemia, compared to controls
(55). Reed and associates later showed that treatment of mice with massive does of
IFN-gamma resulted in improved survival after infection with T. cruzi (57).
During in vitro experiments, when macrophage or heart cell cultures were treated
with IFN-beta, there was no effect on the uptake of T. cruzi (58). However. when the
parasites were treated directly with IFN-beta, decreased uptake of the trypanosomes
by cells was observed (58). Therefore. IFN-beta may be able to interact directly with
the parasite, resulting in decreased uptake of the parasite. When IFN-gamma was applied
to cultures of macrophages, increased uptake and oxidative killing was observed (59).
Therefore. a two-step role for IFNs could be envisioned in resistance to Chagas' disease.
First IFN-beta could protect by limiting the uptake of the parasite by cells. Then. IFN
-gamma could enhance the destruction of the parasite in cells that had been invaded.
Additional studies were carried out with T.b. rhodesiense, one causative agent of
African sleeping sickness. Many different groups have shown that IFNs are produced
in the course of African trypanosome infections (60, 61). In our laboratory, we were
able to show that IFN production correlated with resistance of inbred strains of mice
to trypanosme infection (62). Mouse strains that were genetically susceptible to infection
produced no IFN0 intermediately resistant strains produced only IFN-alpha/beta, and
resistant strains of mouse produced both IFN-alpha/beta and IFN-gamma during the
course of infection with T.b. rhodesiense (62).
We have not been able to conclusivelydemonstratethat the IFN produced during
infection contributes to resistance to T.b. rhodesiense. Treatment of mice with IFNs,
IFN-inducers. or anti-IFNs has not altered the course of infection with T.b. rhodesiense
(63). The course of infection is so complex that it may require several different protocols
and concentrations of IFNs to show direct protective effects on the primary infection.
However. we have shown effects on secondary infections. Mice infected with African
trypanosomes are immunosuppressed, and often succumb to secondary infections (64).
We were able to show that mice that were infected with T.b. rhodesiense and were
producing IFNs were resistant to superinfection with the D variant of encephalomyocarditis
virus (65). This indicates that a mouse strain resistant to infection to T.b. rhodesiense
and producing IFN could have reduced morbidity and mortality as a result of not being
subject to secondary viral infections.
Additional studies were carried out with the amoeba Naecjleria fowleri (66). This
is a free-living amoeba, but in thermally polluted lakes, can infect children and cause
a primary amoebic meningoencephalitis (66). When N. fowleri were treated in vitro with
IFN- alpha/ beta. they were no longer infectious for mice (66).
We have also carried out studies with bacteria. We have been able to show that
IFN-alpha/beta activated mouse macrophages to ingest Escherichia coil and increase
levels of phagocytic enzymes, but IFN-gamma was not as effective in this model (67.
68). In this case. IFN-alpha/beta might be more effective than IFN-gamma.
In additional studies, models of surgical wound infection were used. Individuals
who survive trauma, such as an automobile accident or a gunshot wound, are immuno-
suppressed (69). If these individuals survive the initial trauma, the leading cause of
death is infection due to bacterial sepsis, and antibiotics are usually ineffective (69).
We were able to show using four models of wound infection in mice similar to what
occurs in trauma, that treatment with recombinant IFN-gamma. provided by Genentech.
resulted in inceased survival of the animals (70-73). The bacteria used included Klebsiella
pneumoniae and Escehrichia coll. which are common surgical wound contaminants. There
have been no studies in these models with IFN-alpha to date. but since IFN-alpha/
beta may activate phagocytic cells differently from IFN-gamma, there are exciting research
possibilities with IFN-alpha in this area.
The studies described above indicate that IFNs can demonstrate many
immunoregulatory activities. As a result of these activities, it appears that IFNs can
play a role in resistance to a wide variety of pathogens. IFNs may play a role in
modulating natural resistance to these infections as a result of immunoregulation and
other activities. It remains to be seen whether the use of exogenous IFNs. and IFN-
alpha in particular, can have practical clinical efficacy in reducing morbidity and mortality
of infections for which no effective chemotherapy exists and treatable infections in
hosts that are immuno-suppressed. The door is just beginning to open for experiments
of this nature to be carried out.
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AbStraeI--BELTZ L. A., SONNENFELDG. and KIERSZENaAUMF. 1989. Inhibition by Tr)'panosoma cruzi of
interferon-gamma production by mitogen-stimulated mouse spleen cells. International Journal for
Parasitology 19: 555-559. Infection by Trypanosoma cruzi is accompanied by severe immunosuppression
during the acute period. As part of our studies, to define the alterations caused by Trypanosoma cruzi in
lymphocyte function, we examined in this work the interferon-gamma (IFN-y)-producing capacity of
mitogen-stimulated mouse spleen and human peripheral blood monoauclear cells in the presence or absence
of blood forms of the parasite. Co-culture of phytohaemagglutinin- or concanavalin A-stimulated spleen
cells from normal mice with T. eruzi significantly decreased the levels of IFN-? activity found in the
supernatants at 48 or 72 h. In contrast, human peripheral blood mononuclear cells, though suppressed by T.
cruzi in their capacity to proliferate upon mitogenic stimulation, showed no significant decrease in IFN-?
production. The addition of exogenous IFN-? did not reverse the suppressive effect of T. cruzi on either
mouse or human cells. These results revealed, for the first time, the ability of T. cruzi to impair IFN-y
production by activated mouse lymphocytes. The lack of restoration by exogenous IFN-?suggested that the
reduced levels of this lymphokine were not, at least by themselves, the causative factor of reduced
lymphoproliferation.
INDEX KEY WORDS: Trypanosoma cruzi; Chagas' disease; interferon gamma; immunosuppression.
INTRODUCTION
THE acute phase of Trypanosoma cruzi infection in
mice is accompanied by several manifestations of
immunosuppression, including decreased interleukin
2 (IL2) production and reduced mitogen-induced
lymphocyte proliferation (Hayes & Kierszenbaum,
1981; HareI-Bellan, Joskowicz, Fradelizi & Eisen,
1983; Reed, Inverso & Roters, 1984; Tarleton & Kuhn,
1984). The parasite also suppresses the proliferation of
normal mouse spleen and human peripheral blood
mononuclear cells and in vitro following stimulation
with mitogens or a monocional antibody specific for
an epitope of the T cell receptor complex (Maleckar &
Kierszenbaum, 1983; Beltz & Kierszenbaum, 1987;
Beltz, Sztein & Kierszenbaum, 1988). The binding of
IL2 to its receptor on T lymphocytes triggers both
IFN-7 production (Farrar, Johnson & Farrar, 1981)
and cell division (reviewed by Smith, 1984). Since IL2
production by mouse spleen cells is decreased by T.
cruzi, it is possible that IFN-y synthesis may also be
impaired.
IFN-y plays an important role in host defence
against intracellular parasites, enhancing the in vitro
killing of Toxoplasma gondii, Leishmania donovani and
To whom all correspondence should be addressed.
T. cruzi by macrophages (Pfefferkorn & Guyre, 1983;
Murray, Rubin & Rothermel, 1983; Plata, Wietzerbin,
Garcia-Pons, Falcoff & Eisen, 1984). In vivo, IFN- 7
acts synergistically with anti-T, cruzi antibodies to
decrease parasitemia and prolong the survival of
infected mice (Plata, Garcia-Pons & Wietzerbin,
1987). This lymphokine also affects mitogen-induced
lymphocyte proliferation by either inhibiting or
enhancing T cell activity, depending on the dosage and
time of administration (Sonnenfeld, Mandel &
Merigan, 1978; Friedman & Vogel, 1983). Given the
roles of IFN-y in host defense and lympho-
proliferation, we looked into whether T. cruzican alter
production of this important lymphokine by normal
murine and human lymphocytes and, if so, whether
this alteration plays a role in the suppression of
lymphocyte proliferation.
MATERIALS AND METHODS
Parasites. Trypomastigotes of T. cruzi (Tulahuen isolate)
were purified from the blood of CrI-CDI(ICR)BR Swiss mice
(Charles River Laboratory, Portage, MI) infected
intraperitoneally 2 weeks previously with 2 x 105 blood
forms. The parasites were purified by density gradient
centrifugation over a mixture of Ficoll-Hypaque of density
1.077 (Budzko & Kierszenbaum, 1974) followed by
diethylaminoethyl-cellulose chromatography (Villalta &
Leon, 1979), washed twice by centrifugation (800 x g, 20
555
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min,4"C)andresuspendedinRPMI 1640 medium (Gibe,,
Grand Island, NY) containing 100 i.u. penicillin and 100 pg
streptomycin per ml plus either 2.5 or 5*/. heat-inactivated
(56"C, 20 min) fetal bovine serum (RPMI + 2.5%FBS or
RPMI + 5%FBS, respectively).
Mouse spleen cells (mSC). Spleens were removed from
ether-anesthetized inbred CBA/J mice (Jackson
Laboratories, Bar Harbor, ME). Cell suspensions were
prepared as described previously in detail (Maleckar &
Kierszenbaum, 1983); the nucleated cells were counted and
working suspensions were made in RPMi + 2.5%FBS. Cell
viability, determined by trypan-blue dye exclusion, was
always >99%.
Human peripheral blood mononuclear cells ( hPBMC ). The
hPBMC were isolated from the blood of healthy donors by
centrifugation over a mixture of Ficoll-Hypaque of density
1.077 (350 x g, 45 min, 20"C). The cells collected at the
interface were washed three times by eentrifugation (350 x g,
10 min, 4°C) with serum-free RPM1 1640 medium. The
hPBMC were then resuspended in RPMI + 2.5%FBS. Cell
viability was determined by trypan-blue exclusion and was
always > 99%.
Lymph,proliferation assay. Mouse spleen cells at 2.5 × 106
cells ml -t were incubated in 96-well plates (final culture
volume = 0.1 ml) in the presence or absence of 5 /lg
phytohaemagglutinin P ml - _(PHA; Sigma Chemical Co., St.
Louis, MO), together with or without 2.5 x 106 parasites
ml - _. In some experiments, exogenous recombinant murine
1FN-7 (specific activity 2.3 x 107 units per mg protein,
Genentech, South San Francisco, CA) was added, keeping
the final volume at 0. I ml. Each condition was tested in
triplicate. The cultures were incubated at 37"C (5*/o CO2) for
72 h and 37 kBq 3H-thymidine (Amersham, Arlington
Heights, IL) was present during the last 24 h. The hPBMC
cultures were performed similarly, except that the parasite
concentration was 5 x 106organisms ml- _.When exogenous
IFN-y was added to human cell cultures, we used partially
purified human IFN-y (Meloy Laboratories, Springfield,
VA). All cultures were performed in triplicate and were
terminated by automated harvesting using a MASH II
apparatus (M. A. Bioproducts, Walkersville, MD). The
results were expressed as counts per minute (c.pm.)
representing 3H-thymidine uptake during the last 24 h of
culture.
Measurement of IFN-y. To determine IFN-?" activity,
suspensions of mSC or hPBMC were incubated in sterile 24-
well plates (final culture volume = I ml) at 37"C (5% CO_,)
for 48 or 72 h in the presence or absence of 5/.tg PHA ml - i
with or without 2.5 x 106(for mSC) or 5 x 106(for hPBMC)
T. cruzi ml - _. The latter concentration of parasites was that
found to be the minimal level to consistently decrease the
proliferation of PHA-stimulated hPBMC. Following
passage through 0.22-pm-pore-size filters, the supernatants
were assayed for IFN-?, activity by a plaque reduction assay
using mouse L-929 cells and the Indiana strain of bovine
vesicular stomatitis virus (Sonnenfeld, Mandel & Merigan,
1977). The titer was expressed as units ml- _corresponding to
the reciprocal of the highest dilution that reduced plaques by
50*/,. In this assay, one unit was equivalent to 0.88 NIH G-
002-90451 i reference units and the lower sensitivity limit was
30 units IFN-7 ml- _. Identification of anti-viral activity as
that of IFN- 7 was provided by its lability at pH 2 and
inhibition with anti-murinc IFN-y antibodies (a gift from Dr
E. Havell, Trudeau Institute, Saranac Lake, NY). In the
experiments in which we measured IFN-7 t activity in
supernatants from hPBMC co-cultures with T. cruzi, we used
a radioimmunoassay kit (Centocor, Malvern, MY) which
utilizes two monoclonal antibodies directed at different
epitopes of human IFN-y and is designed to detect only
biologically active material. The lower limit of sensitivity of
this assay was 5 units IFN-:yml- i.
Absorption of murine IFN-y. Aliquots of a solution of
recombinant murine IFN-y (Genentech) were incubated in
24-well plates with or without 5 × 10 6 tO I x 107 T. cruzi
ml _at 37"C for 48 h. After filtration through 0.22-/tin-pore-
size filters, residual IFN-y activity was determined in the
filtrates by the biological assay described above.
RESULTS
Effects ofT. cruzi on IFN- y production in vitro
The levels of IFN-y activity in supernatants of
PHA-stimulated mSC cultures which contained T.
cruzi were significantly lower than those of control,
parasite-free cultures (Table I). A relatively small but
nevertheless significant reduction was demonstrable
48 h after the initiation of the cultures and a more
pronounced effect was seen at 72 h. At these times, the
decreases in 3H-thymidine incorporation due to the
presence of parasites (recorded in parallel cultures)
were approximately 50°/, and > 59*/0, respectively, in
the two repeat experiments (data not shown). Similar
results were obtained when another T ceil-specific
mitogen, concanavalin A (2 jug ml-I), was used in
experiments of identical design (data not shown). No
detectable IFN-_,-like activity was found in the super-
natants of T. cruzi suspensions at concentrations
which suppressed mSC responses, nor did the parasite
induce unstimulated mSC to secrete measurable levels
of IFN-_,.
TABLE I--T, ¢ruzi-INDUCED INHIBITION OF IFN-y PRODUCTION
BY PHA-sTIMULATED MOUSE SPLEEN CELLS*
Material tested IFN-y(units ml-i) measured after
48 h 72 h
mSC < 30 < 30
T. cruzi < 30 < 30
mSC + T. cruzi < 30 < 30
T. cruzi + PHA < 30 < 30
mSC + PHA 58 67
mSC + PHA + T.cruzi 317 <:30?
* The tested materials consisted of the culture supernatants
of mSC (2.5 x 106 cells ml-I) and/or 7". cruzi (2.5 x 106
organisms ml-t) in the presence or absence of 5 _g PHA
ml - _.The supernatants were collected at the indicated times
after initiation of the cultures. This set of results was obtained
with individual cultures and was representative of two
separate repeat experiments.
? This reduction in IFN-_, activity with respect to the
corresponding positive control value was statistically
significant (P < 0.05).
The noted decrease in IFN-y levels might have
resulted from either removal of the iymphokine by the
parasite or reduced production or secretion. This was
tested by incubating aliquots of a solution of
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recombinant murine IFN-?' with or without T. cruzi
for a 48-h period. The IFN- 7activities remaining after
absorption with parasites or mock absorption did not
differ significantly (P > 0.1). Thus, for example, in one
of the experiments aliquots absorbed with 5 × 106 and
1 × 107 parasites ml -I had 357 + 140 and 303 + 51
units IFN-7 ml -I, respectively whereas the mock-
absorbed control had 284 + 74 units IFN-_,mI-_. It is
noteworthy that the concentrations of parasites used
for absorption represented two and four times,
respectively, the level which reduced IFN-7
production in mitogen-stimulated mSC cultures.
.Attempts to reverse the suppressive effect of T. cruzi
with exogenous IFN- y
The lymphoproliferative capacity of mitogen-
stimulated lymphocytes from either infected mice
(Hayes & Kierszenbaum, 1981; Harel-Bellan et al.,
1983) or humans (Teixeira, Teixeira, Macedo & Prata,
1978) has been shown to be impaired. Furthermore,
co-culture of either mSC or hPBMC from normal
individuals with T. cruzi results in significant
suppression of lymphoproliferation (Maleckar &
Kierszenbaum, 1983; Beltz & Kierszenbaum, 1987).
Because IFN-7 can enhance T cell proliferation at
certain dosages and times of administration
(Sonnenfeld et al., 1978), the possibility that the
observed suppression in lymphocyte growth resulted
from the inhibition of IFN-y production by T. cruzi
was explored. To this end, IFN-7 was added to the
cultures so as to attain final concentrations ranging
from 8 to 250 units ml- _and the level of 3H-thymidine
incorporation was monitored. None of these IFN-7
concentrations afforded a significant restorative effect
(Table 2).
TABLE 2--LACK OF RESTORATION BY EXOGENOUS IFN-7 OF THE
CAPACITY OF PHA-sTIMULATED MOUSE SPLEEN CELLS TO
PROLIFERATE AFTER T. cruziolNDUCEDSUPPRE SSION*
3H-thymidine uptake
IFN- _, (in thousand c.p.m.) % Decrease
(unitsml _) mSC + PHA mSC+PHA+T, cruzi
0 15.2 4- 1.0 0.8 + 0.01" 95
8 14.6 4- 1.0 0.8 4- 0.2"1" 95
16 15.9 4- 0.8 0.7 + 0.2"i" 95
32 14.6 4- 0.4 1.0 4- OAt 93
64 14.7 4- 1.7 0.9 4- 0.5t 94
125 13.9 4- 0.5 0.9 4- 0.1"1" 94
250 4.6 4- 0.7 0.9 4- 0.0t 94
* Recombinant murine IFN-y was added at the indicated
concentrations to cultures of mSC (2.5 x 106 cells mI-E)
containing 5 ,ug pHA ml- _ in the presence or absence of T.
eruzi (2.5 x 106 organisms ml-i). Results are the means of
triplicate determinations made with 72-h cultures pulsed with
37kBq 3H-thymidine during the last 24 h. This set of results is
representative of three separate repeat experiments.
t P<0.05 (Student's 't' test) for the reduction in c.p.th.
_th respect to either control, i.e. mSC + PHA with or
without 1FN- y.
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The capacity of mSC to produce IL2 is decreased
following exposure to T. cruzi either in vivo or in vitro
(HareI-Bellan et al., 1983; Beltz & Kierszenbaum,
unpublished results). The addition of IL2 to these
supposed cultures restores their ability to secrete
immunoglobulin (Reed et al., 1984; Tarleton & Kuhn,
1984) and to proliferate following mitogen stimulation
(Beltz et al., 1988). Because IFN-7 has been
reported to increase the expression of IL2 receptors on
both T cells (Johnson & Farrar, 1983) and monocytes
(Herrman, Canistra, Levine & Griffin, 1985), and
higher levels of the IL2 receptor allow cells to
respond to lower concentrations of IL2 (Cantrell
& Smith, 1984), we tested whether IFN-y
would enhance the restorative capacity of IL2. The
presence of 16 or 125 units IFN-7 m1-1
did not overcome T. cruzi-induced suppression of
mSC lymphoproliferation whether or not added
together with a suboptimal level of IL2 (50 units
ml-'). Furthermore, IFN-:rdid not act synergistically
with 100 units IL2 m1-1 (data not shown), a con-
centration which does restore suppressed lympho-
proliferative mSC responses in our system (Beltz et al.,
1988).
TABLE3--LACK OFEFEECTOET. cruzi ON IFN-yPRODUCTIONeY
PHA-sTIMULATED hPBMC*
Material tested IFN-_,(units ml-i) measured after
48 h 72 h
hPBMC _<5 _<5
T. cruzi _<5 < 5
hPBMC + T. cruzi < 5 < 5
7".cruzi + PHA < 5 < 5
hPBMC + PHA 120 125
hPBMC + PHA + T. cruzi 96 119
* The tested materials consisted of the culture supernatants
of hPBMC 1.25 x- 106 cells ml -t) and/or 7".cruzi (5 x 10 6
organisms ml -I) in the presence or absence of 5 gg PHA
ml - _.The supernatants were collected at the indicated times
after initiation of the cultures, filtered and tested for IFN-?
activity by radioimmunoassay. This set of results was
obtained with individual cultures and was representative of
two separate repeat experiments. None of the noted
reductions in IFN-7 activity due to the presence of T. cruzi
was statistically significant.
We next examined whether T. cruzi would also
inhibit IFN-_, production or secretion by human
lymphocytes. As can be seen in Table 3, the presence of
5 x 106 T. cruzi ml -I in cultures of PHA-stimulated
hPBMC did not lead to a significant reduction in
IFN-7 levels in the supernatants. The addition of
exogenous human IFN-7 did not restore the
suppressed lymphoproliferative response of hPBMC
exposed to T. cruzi whether or not IL2 was present
(data not shown).
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DISCUSSION
These results show, for the first time, that T. cruzi
can diminish the capacity of mouse lymphocytes to
produce IFN-y upon activation by mitogenic stimuli.
Immunosuppression of T. cruzi in vitro has been
shown not to be due to nutrient consumption by the
parasite (Maleckar & Kierszenbaum, 1983; Beltz &
Kierszenbaum, 1987) and the present data showed
that the flagellate does not absorb, consume or
inactivate IFN-y. Furthermore, in our culture system
the numbers and the viability of mouse cells co-
cultured with T. cruzi are comparable at 48 and 72 h
with those of parasite-free cultures (Maleckar &
Kierszenbaum, 1983). Thus, the noted reduction in
IFN-y activity was probably the result of inhibited
production and/or secretion.
Decreased proliferation by spleen cells from
infected mice or by normal mSC incubated with T.
cruzi in vitro is paralleled by decreases in IL2 (Harel-
Bellan et aL, 1983; Beltz & Kierszenbaum,
unpublished results) and 1FN- y (Table 1) production.
In contrast, T. cruzi is unable to decrease IL2
production by hPBMC under optimal culture
conditions (Beltz et al., 1988) and, as reported herein,
also had no significant effect on IFN-y production by
hPBMC (Table 2). Thus, there would appear to exist a
notable difference in how the parasite affects mSC and
hPBMC responses to PHA. However, the present data
do not clarify whether this difference in the
suppressive activities of T. cruzi toward mSC and
hPBMC stems from the use of different populations of
lymphocytes or from an actual disparity in mouse and
human lymphocyte responses to the parasite.
Although reduced IFN-7 production/secretion is a
major consequence of T, cruzi-induced suppression of
mSC, it is not, at least by itself, the explanation for
such suppression, since exogenous IFN- 7 failed to
restore responsiveness in terms of lymphoprolifer-
ation measured by 3H-thymidine uptake.
T. cruzi suppresses proliferation ofhPBMC (Beltz &
Kierszenbaum, 1987). Insufficient levels of IFN-y or
IFN-y plus IL2 do not seem to be the cause for this
suppression since no significant drop in the level of
IFN-ywas observed in these cultures and neither IFN-
7 nor IL2, added to the cultures, separately or
together, corrected the suppression caused by the
presence of the parasite. IFN-y and IL2 are elements
of a complex regulatory network and are able to affect
each other's synthesis and utilization (Farrar et al.,
1981; Johnson & Farrar, 1983; Herrman et al., 1985),
with IFN-y production being upregulated by IL2
(Farrar et al., 1981). Since T. cruzi decreases the
production of both IL2 and I FN- ?' by activated mSC,
it is possible that the parasite's ability to inhibit
synthesis or secretion of IL2 is at least partially
responsible for the decrease in IFN-y production/
secretion. It should be noted, however, that
lymphocytes from mice infected with Trypanosoma
brucei have an impairment in the secretion of IL2 but
not IFN-y (Sileghem, Hamers & de Baetselier, 1987),
demonstrating that normal IL2 levels may not be an
absolute requirement for optimal IFN-y synthesis.
Conceivably, T. cruzi could exert independent
suppressive effects on T cells; this remains to be
studied.
Although the deficient capacity of mSC to produce
or secrete IFN-r after exposure to T. cruzi does not
appear to determine suppressed lymphocyte
proliferation, occurrence of this phenomenon in vivo
could alter the capacity of other host cells to interact
with the parasite. For example, macrophages take up
and destroy the parasite, and IFN-yhas been shown to
enhance these functions (Wirth, Kierszenbaum,
Sonnenfeld & Zlotnik, 1985). Furthermore, IFN-y
appears to increase the resistance of fibroblasts to T.
cruzi infection in vitro (Plata et aL, 1984) and,
synergistically with anti-?', cruzi antibodies, to
decrease the parasitaemia and increase the survival
time of infected mice (Plata et aL, 1987).
In closing, it should be noted that the present data
do not clarify whether reduced IFN-y production by
mSC in the presence of T. cruzi is an indirect
consequence of infection of accessory cells, e.g.
macrophages, by the parasite.
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Several studies have been carried out that demonstrate that immunological
activities of lymphocytes can be affected by spaceflight or by models that
attempt to simulate some aspects of weightlessness. Included among these are
the responses of lymphocytes to external stimuli such as mitogens and viruses.
When cultures of lymphocytes were flown in space, the ability of the
lymphocytes to respond to mitogens was inhibited. Similar results were
obtained when lymphocytes from astronauts or animals just returned from
space were placed into culture immediately upon return to earth, and when
models of hypogravity were used. Lymphocytes placed in culture during
spaceflights produced enhanced levels of interferon compared to control
cultures. When cultures of lymphocytes were prepared from cosmonauts or
rodents immediately upon return to earth, interferon production was
inhibited. These results suggest that space flight can have profound effects on
lymphocyte function, and that effects on isolated ceils may be different from
that on cells in the whole organism.
INTRODUCTION
Over the years, it has become apparent that spaceflight can have profound
effects on biological systems. Included among those systems is the immune
system of mammals (Barone and Caren, 1984; Jackson and Warner, 1986). In
most cases, suppression of immune responses has occured, but there have been
occasional reports of immune enhancement (Barone and Caren, 1984; Jackson
and Warner, 1986). Similar results have occurred when ground-based models
of weightlessness have been utilized.
The mechanism of the effects of spaceflight on immune responses remains
to be established. Weightlessness, stress, and low-level radiation could all
contribute to alterations in immune responses. Although studies on the effects
of spaceflight on immune responses have been limited, some interesting
observations have been made. In this monograph, I will review the effects of
spaceflight and modeling of weightlessness on lymphocyte function as
determined by the response of the lymphocytes to external stimuli such as
mitogens.
EFFECTS OF SPACEFLIGHT AND MODELING ON THE BLASTOGENIC RESPONSE OF
LYMPHOCYTES
Several studies have been carried out by obtaining the blood of
astronauts/cosmonauts immediately after return from spaceflight. Blood was

also obtained from astronautsand cosmonauts before flight, and in some cases,
during flight, to allow for the determination of the kinetics of changes in
immune responsiveness. In these experiments, white blood cells were
separated from the blood and placed in tissue culture. Mitogens, such as
phytohemmaglutinin or concanavalin-A were added to the cultures. Over
time, lymphocytes from normal individuals would divide and incorporate 3[H]-
thymidine, indicating a blastogenic response of the lymphocytes to the
mitogen. The blastogenic response to lymphocytes requires interaction with
another cell type, the macrophage, as well as interaction with soluble
regulatory factors known as cytokines. The blastogenic response and the
production of cytokines are indications of a normal functioning immune
system.
Several experiments were carried out to determine the effects of
spaceflight on lymphocyte blastogenesis. In most cases (Table l), the
blastogenic response of lymphocytes to mitogens was inhibited severely in
cells obtained from individuals immediately after return to earth (Fischer et
ai., 1972; Kimzey et al., 1975 and 1976; Criswell and Cobb, 1977; Lesnyak and
Tashputalov, 1981; Taylor, 1983; Taylor and Dardano, 1983; Konstantinova et al.,
1985; Taylor and Neale, 1986). The duration of the flights was from several
days to several months. Recent reports (Taylor, 1983; Taylor and Dardano, 1983;
Taylor and Neale, 1986) have also indicated decreased levels of circulating
monocytes in astronauts after spaceflight (Table 1). Since the monocyte is an
important accesory cell for the blastogenic response of lymphocytes, this
could have contributed to the suppression observed.
While the results described above indicate that blastogenesis of
lymphocytes in response to mitogens was inhibited when the cells were taken
from individuals immediately after return from space, the question still
remained whether spaceflight could affect blastogenesis of iymphocytes
actually held in tissue culture during spaceflight. This question was addressed
by a series of experiments using simulation and actual flight studies carried
out by Cogoli and his associates.
Human peripheral blood leukocytes were placed in culture in a fast-
rotating clinostat. This clinostat has constantly changing gravity vectors, and
has been used as a technique for simulating microgravity conditions (Cogoli et
al., 1980). Lymphocyte blastogenesis was inhibited greatly when the cells
were maintained in this clinostat (Table 2) (Cogoli et al., 1980).
In addition, an incubator was developed that allowed the performance of
similar experiments during spaceflight. A drastic inhibition of lymphocyte
blastogenesis was observed when human peripheral blood leukocytes were
placed in culture and challenged with mitogen during space flight (Table 2)
(Cogoli and Tschopp, 1984 and 1985; Tschopp and Cogoli, 1984). When the cells
were incubated in a I G centrifuge during spaceflight, much of the
blastogenic capacity was retained (Table 2), indicating that the microgravity
conditions of spaceflight contributed to the inhibited blastogenesis that was
observed during spaceflight (Cogoli and Tschopp, 1984 and 1985; Tschopp and
Cogoli, 1984).
EFFECTS OF SPACEFLIGHT AND MODELING ON THE PRODUCTION OF INTERFERON
AND OTHER CYTOKINES BY LYMPHOCYTE_
Several experiments were also carried out to determine the effects of
spaceflight on cytokine production by lymphocytes after mitogenic or
antigenic stimulus. Cytokines are molecules that are produced by cells that are
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important messengers for the development of immune responses. Without
them, lymphocytes and monocytes cannot communicate effectively with each
other and immune responses cannot be mounted. The cytokines that have been
utilized for space studies are the interferons, important antiviral, anti-cancer
and immunoregulatory molecules, and interleukin-3, an important
immunoregulatory molecule.
In an Hungarian-Soviet study, blood was removed from cosmonauts and
peripheral blood leukocytes were placed in culture during spaceflight (Talas
et al., 1983 and 1984). When the cells were challenged with a variety of
mitogens and other interferon inducers such as purified protein derivative of
Mycobacterium tuberculosis, Newcastle disease virus, and polyriboinosinic-
polyribocytidylic acid, interferon-alpha production was enhanced compared
to ground controls (Table 3). However, when peripheral blood leukocytes were
harvested from cosmonauts immediately upon return to earth after
spaceflight, interferon-alpha production in response to Newcastle disease
virus challenge of leukocytes was inhibited severely (Table 3) (Talas et al.,
1983 and 1984). The number of replicates in this series of experiments was
small, and extensive time course experiments to determine how interferon
production would have varied in cell cultures from the same individuals on the
ground were not carried out. Nevertheless, these experiments suggest that the
in vitro response of lymphocytes to spaceflight may differ from the effects of
spaceflight on lymphocytes of the intact host.
Inhibited interferon production after simulated weightlessness and
spaceflight of animals was also observed. In the first set of experiments, rats
and mice were maintained in an antionhostatic, hypokinetic, hypodynamic
supension system that models some aspects of weightlessness (Morey-Holton
and Wronski, 1981; Musacchia et al., 1980; Steffen et al., 1984). In this model,
the rodents are suspended with a head-down tilt and no load bearing on the
hind limbs. This results in simulation of some of the effects of microgravity.
When the mice or rats were challenged with polyriboinosinic-
polyribocytidylic acid, there was inhibited interferon-alpha/beta production
in antiorthostatically suspended rodents compared to normally housed controls
(Table 4) (Sonnenfeid et al., 1982; Rose et al., 1984). The inhibition was
transient, as a return to normal caging after suspension resulted in recovered
ability to produce interferon. Suspension in an orthostatic fashion (no-head
down tilt), which does not simulate the effects of microgravity, had no effect
on the capacity of mice to produce interferon-alpha/beta (Table 4) (Rose et
al., 1984). It must be noted that when animals are challenged systemically
with an interferon inducer such as polyriboinosinic-polyribocytidylic acid,
many cell types other than lymphocytes can be induced to produce
interferon-alpha/beta. Therefore, these experiments went beyond just
measuring the effects of suspension on lymphocyte responses to mitogenic
stimuli.
In a second series of experiments, rats were flown in Space Shuttle SL-3.
Upon return to earth, spleen cells containing lymphocytes were harvested,
placed in culture, and challenged with the mitogen concanavalin-A (Gould et
al., 1987). After the appropriate period of incubation, the cell culture
supernatant fluids were harvested and assayed for production of two
cytokines, interferon-gamma and interleukin-3. Interleukin-3 is another
important messenger produced by lymphocytes after mitogenic challenge,
providing immunologically significant signals to cells (Gould et al., 1987).
Cells from rats that had been flown for one week showed very significant
inhibition of the production of interferon-gamma, but no effect on
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interleukin-3 production (Table 5) (Gould et al., 1987). The results with the
interferon-gamma supported previous findings in human flight and rodent
suspension studies indicating that interferon-alpha/beta was inhibited.
However, the lack of effect of spaceflight on interleukin-3 production
indicates that all responsesof lymphocytesto mitogens are not affected in the
same fashion by spaceflight.
CONCLUSIONS
The studies described above indicate that spaceflight and models that
simulate microgravity can have profound effects on the responseof
lymphocytesto mitogens. The effects of spaceflight appear to be selective, in
that all responsesof lymphocytesto mitogensare not affected in a similar
fashion. In addition, the effects of spaceflight on isolated lymphocytes in
culture may differ from effects when lymphocytes are jn yiv9 in a whole
animal surrounded by other cells, soluble messengers and interact with
systems other than the immune system.
The mechanism of the effects of spaceflight on immune responses remains
to be established. Several possiblities exist. Among them are: 1) direct effects
of microgravity on lymphocytes, 2) inability of lymphocytes to interact
directly with other cell types such as monocytes/macrophages, 3) inability of
lymphocytes to produce cytokines, 4) inability of iymphocytes to respond to
signals from cytokines, 5) inability of antigenic or mitogenic signals to reach
lymphocytes because of fluid-shifts induced during spaceflight, and 6)
impaired function of lymphocytes because of faulty interaction with other
non-immunological systems such as the neuroendocrine system. Other
potential mechanisms surely exist. The study of these mechanisms should
progress with time.
Determination of the effects of spaceflight on lymphocytes should yield
other fascinating information. Since the immune system is responsible for
resistance to infection, the study of lymphocytes should help to determine if
long-term exposure to spaceflight conditions could compromise resistance.
The ability to produce large amounts of cytokines as a result of genetic
engineering probably indicates that enhanced production of cytokines as a
result of spaceflight will not be an effective technique for mass production of
eytokines. However, studying the response of lymphocytes to spaceflight may
aid in our understanding of how the immune response is regulated and may
allow the discovery of new cytokines whose actions are masked in normal
ground conditions.
p
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TABLE 1
EFFECTS OF SPACEFLIGHT ON THE ABILITY OF SUBJECTS' CELLS TO RESPOND TO
MITOGENS UI:_N RETURN TO EARTH
Effect on Blastogenesis l_ff¢ct on Monocyte
N o n e Not Tested
Inhibited Not Tested
Inhibited Decreased
Number Reference
Fischer, 1972
Kimzey, 1975-6
Criswell, 1977
Lesnyak, 1981
Konstantinova
1985
Taylor, 1983,
1983, and 1986
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TABLE 2
EFFECTS OF SPACEFLIGHT ON IN VITRO BLASTOGENESIS
Effect of Centrifugation
Restored
Effect on Blastogenesis
Inhibited
References
Cogoli, 1984
and 1985
Tschopp, 1984
HYPOGRAVITY DUE TO
CLINOSTAT ON THE GROUND
Inhibited Cogoli, 1980
TABLE 3
EFFECT OF SPACEFLIGHT ON HUMAN INTERFERON PRODUCTION
Situation
Leukocytes in
Culture in Space
Leukocytes
Harvested after
Return from Space
Effect on lnlerferon-Alpha
Enhanced
Inhibited
Reference
Talas, 1983 and 1984
Talas, 1983 and 1984
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TABLE 4
EFFEL-_I'S OF ANTIORTHOSTATIC SUSPENSION ON INTERFERON PRODUCTION
Treatment Effect
Rat - 2 week
Mouse- 1 week
Mouse- 1 week
+ 1 week normal cage
Mouse- 1 week
orthostatic suspension
on l.nlerferon-A! pha/Bcta R efe re n c e
I n h i b i t e d Sonnen feld,
Inhibited Rose, 1984
Recovered Rose, 1984
None Rose, 1984
1982
TABLE 5
Duration
1 week
1 week
EFFECT OF SPACEFLIGHT ON RAT CYTOKINE PRODUCTION
of Flight Cytokine Effect Reference
Interferon-gamma Inhibited Gould, 1987
lnterleukin-3 Normal Gould, 1987
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A ground-based model to study the effects of weightlessness
on lymphocytes
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Summary - The mitogenic response of human lymphocytes was found to be markedly reduced in weightlessness conditions as compared
to normal gravity. One possible explanation is that due to the non-existent sedimentation in space the lymphocytes could not adhere
and spread on a substratum. Thus, we investigated the effect of substratum adhesiveness on lymphocyte responsiveness by reducing
and blocking cell adhesion with poly-HEMA in a simple on-ground system. Lymphocyte adhesiveness was assessed by measuring
the proportion of non-adhesive, slightly, and strongly adhesive 5tCr-radiolabelled cells on uncoated and poly-HEMA coated plastic.
The amount of cell spreading on surfaces with varying adhesiveness was determined by measuring the area of cells. Cells grown on
medium and thick poly-HEMA films were rounded in shape. By contrast, on tissue culture plastic, they showed clear signs of spread-
ing. The mitogenic response of lymphocytes grown on thick poly-HEMA films was reduced by up to 68°70 of the control (tissue cul-
ture plastic). Interferon-y production was virtually nil when the cells were grown on the least adhesive substratum. These results show
that activated lymphocytes need to anchor and spread prior to achieving an optimal proliferation response. We conclude that decreased
lymphocyte adhesion could contribute to the depressed in vitro lymphocyte responsiveness found in the microgravity conditions of
space flight.
lymphocyte I activation / adhesion / poly-HEMA / space flight / microgravity
Introduction
The in vitro responsiveness of human lymphocytes to mito-
genic lectins is remarkably reduced in weightlessness
(microgravity). On 2 Shuttle missions we have unequivo-
cally demonstrated that the mitogenic response to con A
was severely reduced by 90-97% under microgravity con-
ditions compared with a 1 g control [2, 8, 9]. These ob-
served in vitro effects in space have been explained as being
due to reduced cell-cell contacts [20], and other, still
unidentified factors [9]. However, an analysis of the cell
aggregates using electron microscopy in flight and ground
samples suggested that the cell-cell interactions were not
affected by microgravity conditions [8, 9].
The proliferation of most cells is dependent upon at-
tachment to a substratum. Folkman and Moscona [11]
studied the role of cell shape in determining growth charac-
teristics of attachment-dependent mammalian cells. They
decreased the adhesiveness of tissue culture plastic by ap-
plying increasing concentrations of poly-HEMA to control
the extent of cell spreading. Cells grown on the least adhe-
sive substrata were rounded in shape whereas those grown
on more adhesive substrata were flatter. Cell growth,
measured by DNA synthesis, was highly correlated with
cell shape. The flattened cells had significantly higher
Abbreviations: con A, concanavalin A; HBSS, Hank's balanced salt so-
lution; P, probability of error; PHI, PH2, and PH4, 10-, 100-, and
10000-fold dilution of poly-HEMA stock solution; poly-HEMA, poly
(2-hydroxyethyl methacrylate)
growth rates than the rounded ones. Thus, cell adhesion
and spreading are essential for optimal growth of mam-
malian attachment-dependent cells (bovine aortic en-
dothelial cells, WI-38 cells, A-31 cells, and Swiss 3T3 cells).
Research in the field of lymphocyte contacts has focused
upon lymphocyte-cell interactions. In vitro studies have
shown the significance of cell-cell contacts for optimal an-
tigenic or mitogenic stimulation of lymphocytes [16, 21].
At least two types of such interactions have been identi-
fied. Firstly, recirculating lymphocytes leave the blood by
adhering to and migrating between endothelial cells in
specific organs [14], in particular lymphoid sites, which
have been termed lymphocyte homing [12]. The specific
cell surface structures iymphocytes use for this process
have been called homing receptors [12]. On lymphocytes,
two groups of heterodimer receptors were found that are
similar to extracellular matrix receptors from mammalian
cells [4, 22]. One group includes the lymphocyte function-
associated antigen LFA-1, Mac-l, and the p150,95
complex; the other group comprise the "very late anti-
gens" (VLA-1 to VLA-5). Secondly, the CD3-T cell recep-
tor complex of helper T cells recognize fragments of
foreign antigens in association with class II MHC proteins
on the surface of accessory cells [6, 25]. Thus, interactions
between adhesion proteins and receptors involved in
lymphocyte-cell contacts are assumed to play a vital role
in the early events of an immune response.
Regarding lymphocyte-substratum interactions, the
present body of knowledge is more limited. Sundqvist and
Wanger [23], and Wanger and Sundqvist [26] reported that
human lymphocytes attach and spread on glass and plas-
tic surfaces. Moreover, the mitogenic response of lympho-
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cytes was lower on bacterial plastic compared with tissue
culture plastic [23]. This finding suggests that lymphocyte
adhesion and spreading are related in order to achieve an
optimal proliferation response. However, nothing is
known as to how a complete blocking of lymphocyte adhe-
sion, attachment and spreading affect the proliferation
response. This is important to know in order to analyze
earlier space flight experiments and to devise future in vitro
lymphocyte studies in space. Recent in vitro experiments
performed in weightlessness [2, 8, 91 indicate that lack of
sedimentation and convection could markedly modify the
mitogenic response of lymphocytes by reducing cell-
substratum contacts. Thus, the depressed lymphocyte
responsiveness observed in vitro under microgravity con-
ditions could result from changes in the lymphocyte sur-
face milieu and cell shape. This underscores the need to
continue to clarify the effect of lymphocyte-substratum
adhesion on responsiveness. We reduced the adhesiveness
of tissue culture plastic by applying increasing concentra-
tions of poly-HEMA. We have measured amounts of lym-
phocyte adhesion, and correlated these to changes in cell
area as a means to estimate spreading, responsiveness, and
interferon-y production. This allows us to, in part, explain
the results of lymphocyte in vitro experiments performed
during space flight.
Materials and methods
Preparation of human peripheral lymphocytes
Lymphocytes were obtained from healthy donors by Ficoll-
Hypaque gradient centrifugation [3, 191. After determining the
viable cell number (trypan blue exclusion) the cells were
resuspended in 2-20 ml RPMI-1640 (Gibco, Paisley, Scotland,
cat no 042/0251 IH) medium supplemented with 40 mM Hepes
(Sigma, St Louis, USA, cat no H 3375), 5 mM NaHCO3,
50 mg 1-l gentamicin (Biochrom KG, Berlin, Germany, cat no
A 2712), 20% pooled type 0 human serum, and 4 mM glutamine
(Biochrom KG, Berlin, Germany, cat no K 0282).
Lymphocyte proliferation assay
The procedure has been described earlier [2, 8]. Briefly, 106lym-
phocytes in 1 ml (in triplicate) were stimulated in multidishes
(Nunc, Roskilde, Denmark, cat no 1-43982) by the addition of
25 /_g ml -J con A (Pharmacia, Uppsala, Sweden, cat
no 17-0450-01). After incubation for 72 h the rate of DNA syn-
thesis was determined by the incorporation of 3H-labelled
thymidine (Amersham, Buckinghamshire, UK, TRK. 418). For
this, the lymphocytes were resuspended and transferred from the
wells into 5 ml tubes. 20/A labelled thymidine (2/_Ci) was added
to 1 ml lymphocyte culture which was incubated for 2 h at 37°C.
The labelling was stopped by the addition of 3 ml ice cold saline
(9 g/l). Following rapid filtration over Whatman GF/C filters
and 2 rinses of the tubes with 3 ml saline, the DNA was precipi-
tated on the filters with 2 washes with 3 ml ice-cold trichloroa-
cetic acid (5%) and 2 washes with 3 ml ice-cold ethanol.
Radioactivity retained by the dried filters was counted in a scin-
tillation spectrometer (Beckman Scientific Instruments, Irvine,
USA, model LS 1800).
5tCr labelling
Lymphocytes were labelled with S_Cr by incubation of ceils at
12.5 × 106cells ml- _with 250/_Ci ml- _Na25_CrO4 (Amersham,
Buckinghamshire, UK, cat no CJS.4) for 90 min at 37°C in medi-
um without supplements [10, 27]. After washing the cells 2-times
with medium the supplements were added and the cell density
was adjusted.
Poly-HEMA coating of multidishes
Slideflasks (Nunc, Roskiide, Denmark, cat no 1709210) and mul-
tidishes were coated with dilutions of poly-HEMA (Aldrich
Chemical Company, Milwaukee, USA, cat no 19206)according
to Folkman and Moscona [11]. 6 g poly-HEMA was dissolved
in 50 ml 95°/0 ethanol and the mixture was slowly stirred over-
night at 37°C. The viscous solution was then centrifuged at
2 500 rpm for 30 min to remove possible particles. This stock
solution was diluted 10-, 100-, and 10000-fold with ethanol
(termed PH l, PH2, and PH4, respectively). 200 td or 947 IA dilut-
ed poly-HEMA was filled in triplicates into the wells of the mul-
tidishes (1.9 cm 2) and slideflasks (9 cm2), respectively. The culture
vessels were dried (lids open) at room temperature for 48 h in
a sterile workbench free of vibrations.
Lymphocyte adhesion assay
106S_Cr-labelled cells in 1 ml of medium were activated adding
con A (25/_g/I) and placed into the wells of multidishes (in tripli-
cate). The cultures were incubated for 4 h at 37°C. First, 50 #1
of the supernatant without cells were sampled to check the via-
bility of the lymphocytes [27]. This cell viability test relies on
the fact that chromate is taken up by living cells and reduced
by the metabolism. The reduced form remains trapped within
the ceils, unless the cell membrane becomes leaky or the cell lyses.
Thus, radioactivity detected in a cell culture supernatant of 5JCr-
tagged cells is a means to check cell viability [27]. The rest of
the supernatant and nonadhering cells were then aspirated (dishes
tipped at an angle of 30°) using a pipette (samples 1), and replaced
by pre-warmed HBSS. After shaking the dishes on a gyratory
shaker for 15 s (220 rpm, 4 mm amplitude) to suspend loosely
bound cells, the supernatant was removed again (sample 2). Last-
ly, adhering lymphocytes were lysed with NaOH (950/A, 2 M)
(sample 3). Radioactivity in the samples were determined in a
y-counter. The proportion of cells in the 3 samples was calculat-
ed by relating the radioactivity recovered in the 3 fraction to the
original radioactivity in the total cell suspension (100°70).
Lymphocyte spreading
Immediately after the addition of con A the cell suspension (4 ml
containing 4 × 106 cells) was loaded into slideflasks and in-
cubated for 18 h at 37°C. The cells were fixed by the addition
of 800 tzl glutaraldehyde (10°70) for 20 rain. After removing the
liquid by aspiration, the bottom of the slideflasks, where the cells
had bound, was separated and used as a microscopy slide. The
fixed cells were allowed to dry at a room temperature, stained
with Giemsa, mounted in a light microscope (1 250-fold magnifi-
cation), and photographed. The cell area of 80-100 lymphocytes
from 4 different sites was determined on a graphic tablet (Sum-
magraphics) connected to a Macintosh computer (Software : Mac-
Draft and StatView) by following the lymphocyte contours.
Cytotoxicity and mitogenicity of poly-HEMA
Cytotoxic and mitogenic effects of poly-HEMA per se on hu-
man lymphocytes was tested as follows: 5_CrO:labelled lym-
phocytes were incubated in poly-HEMA coated multidishes
(PHI, 2, and 4) and radioactivity in the supernatant to check
for cell viability was assessed after 4 and 72 h [27]. To inves-
tigate whether poly-HEMA is mitogenic for human lymphocytes,
the lymphocyte responsiveness was measured in poly-HEMA
coated dishes (PHI, 2, and 4) and compared with the mitogenic
responsiveness in uncoated dishes without the addition of con A.
Determination of interferon-)" concentrations
Inter feron-_-is a T-lymphocyte specific lymphokine released into
the culture medium following antigen or mitogen stimulation.
Following an incubation of 72 h at 37°C, culture supernatants
were frozen and stored at - 20°C until ready for analysis.
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Interferon- 7 was determined in the supernatants by a radioim-
munoassay method (Centecor, Inc, Malvern, PA, USA).
Statistical analysis
Nonparametric test techniques for non-matched samples were
applied. The Kolmogorov-Smirnov test (2-tailed) checks for
differences in the median and homogeneity of all sort, whereas
the Wilcoxon-Mann-Whitney U-test (2-tailed) is more powerful
in detecting differences in the medians. P levels -->0.05 were ac-
cepted as significant.
Results
We first tested whether poly-HEMA is cytotoxic or mito-
genic for human iymphocytes. The 5_Cr-radioactivity
recovered from lymphocyte culture supernatants of cells
grown on poly-HEMA never exceeded the values of un-
coated controls (5 experiments, results not shown). Since
51Cr is retained by viable cells, but not by leaky or lysed
cells, this finding means that poly-HEMA coated culture
surfaces are not cytotoxic for human lymphocytes. To de-
tect a possible mitogenic effect of poly-HEMA, the incor-
poration of acid-precipitable radiolabelled thymidine
following a 72 h incubation of unstimulated cells placed
on uncoated plastic and poly-HEMA coated surfaces was
measured. No significant differences was found between
the two sets of experiments (5 experiments, results not
shown). Therefore, the dose of poly-HEMA used in our
experiments is neither mitogenic nor toxic to human lym-
phocytes.
The effect of increasing the thickness of the poly-HEMA
film on adhesiveness of con A activated lymphocytes is
illustrated in figure 1. The proportion of non-adhering cells
(represented by sample 1) increased with increasing thick-
ness of the poly-HEMA films. In the control, 23°70 of the
radioactivity was found in sample 1, compared to 74°7o of
the highest poly-HEMA concentration used (PHI). Radi-
oactivity in sample 2 (loosely bound cells) was highest in
the wells with the intermediate poly-HEMA dilutions
(PH2). The proportion of adhering cells (represented by
sample 3) increased with increasing adhesiveness of the
substratum. Almost no cells attached in the wells coated
with the thickest polymer film (3°7o); 22°7o and 42°7o of the
cells were recovered from the wells with the thinner coat-
ings, PH2 and PH4, respectively. In the control, 59% of
the original radioactivity was recovered in this fraction.
Clearly, an inverse relationship exists between the thick-
ness of the poly-HEMA film and lymphocyte adhesiveness.
The influence of substratum adhesiveness on the shape
of activated lymphocytes was determined by assessing the
cell area of adhering lymphocytes under a light microscope
as an index of the extent of lymphocyte spreading
(figure 2). We were unable to estimate the area of lym-
phocytes when using the thickest poly-HEMA layer as a
substratum (PH 1) since lymphocyte adherence was so poor
that too few cells would be available for statistical analy-
sis. By contrast, adhesion to the thinest film used (PH4)
did not reveal any change in cell area compared with the
control (data not shown). However, a statistically signifi-
cant difference in the area of attached lymphocytes was
detected on the medium dense polymer film (PH2). A sig-
nificantly higher proportion of activated lymphocytes was
spherical and smaller in area compared with a control af-
ter culturing for 18 h on poly-HEMA (PH2) in 5 indepen-
dent experiments (table I).
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Fig 1. Effect of substratum adhesiveness on lymphocyte adhe-
sion. 5_Cr-labelled lymphocytes were activated with con A and
seeded on uncoated plastic (control) and on three different poly-
HEMA films with decreasing adhesiveness (PH4, PH2, and PHI,
which refer to a 10'000-, 100-, and 10-fold dilution of the poly-
HEMA stock solution). Following an incubation of 4 h at 37°C,
for each type of coating, the amount of radioactivity was meas-
ured in the three cell samples as indicated below the graph. The
amount of radioactivity recovered in these 3 samples was ex-
pressed as a percentage of the total amount or radioactivity used
in the amount of cells to be seeded on a specific type of coating.
Each value is the mean (_+ sd) from 5 experiments (ie 5 differ-
ent donors). Statistical significance relative to the control was
tested using the Mann-Whitney-U-test (2-tailed; *P <_ 0.005).
Table I. Effect of substratum adhesiveness on cell area. Immedi-
ately after con A addition, lymphocytes were plated on culture
plastic or poly-HEMA coated plastic. The mean of 5 experiments
(ie 5 different donors) is displayed. The median is given in brack-
ets. Significant differences between control and assay were iden-
tified using nonparametric statistics (Kolmogorov-Smirnov-test).
Cell area (t_m2)
Exp No coating poly-HEMA Statistical
(Donor) (controO (PH2) coating analysis
1 44.1 (39.2) 36.0 (36.7) *
2 48.1 (43.1) 40.5 (39.5) **
3 43.1 (40.6) 35.8 (35.1) **
4 49.5 (43.4) 39.3 (37.0) **
5 47.8 (42.8) 39.6 (37.8) **
P _ 0.005; **P _< 0.001
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It is interesting that no large cells (> 83 #m 2) were ob-
served in the poly-HEMA coated wells. By contrast, in all
5 experiments the occurrence of large lymphocytes was not-
ed in the control wells. On average, 13°70 of the cells in
the uncoated controls exhibited an area of between 83 and
165 tzm 2. Furthermore in the uncoated wells the main peak
of areas generally showed a shift in the distribution of cell
size which included larger lymphocytes. This was never ob-
served in the poly-HEMA coated wells. Likewise, only the
lymphocytes grown in the control wells showed the typi-
cal signs of cell spreading (a broad rim of cytoplasm
around the nucleus and filopodia). These findings suggest
that the lymphocytes cultured on poly-HEMA could not
anchor and spread. In attachment-dependent cells,
proliferation is related to anchorage and spreading. We
then tested the effect of reduced anchoring and spreading
on activated lymphocytes and measured proliferation by
the uptake of radiolabelled thymidine after 72 h (fig 3).
We determined that lymphocyte proliferation is inversely
related to the thickness of the poly-HEMA film. Lympho-
cyte responsiveness was reduced by up to 68°7o of the
control at PHI (fig 3). At the lowest poly-HEMA dilu-
tion (PH4), lymphocyte responsiveness was unaffected.
When cell-substratum interactions are reduced after
con A activation, lymphocytes cannot proliferate normal-
ly. Consequently, other lymphocyte activation events as-
sociated, such as interferon-y production, should also be
affected. In 2 separate experiments the production of
interferon-T was greatly reduced after plating con A acti-
vated lymphocytes on the thickest poly-HEMA coated
plastic (table II).
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Discussion
Poly-HEMA is a hydrophobic polymer that prevents cells
from anchoring to and spreading on the coated surface.
With increasing concentration of the polymer solution ap-
plied, there is a smaller left suitable area for establishing
contact. Poly-HEMA is not cell-toxic as Folkman and
Moscona [11] and as confirmed by us. In addition, Poly-
HEMA has no mitogenic effect on human lymphocytes.
Non-toxicity and non-mitogenic of poly-HEMA are im-
portant pre-requisites for the experiments presented here.
Our results obtained in vitro show that the mitogenic
response of human peripheral blood lymphocytes is
markedly reduced when cell adhesion to the substratum
is excluded. Previous studies [23, 26] have shown that hu-
man lymphocytes attach to adequate substrata and display
signs of cell spreading. However, the effect of completely
preventing lymphocyte adhesion to a substratum on lym-
phocyte responsiveness has not been assessed before. This
is important with respect to in vitro flight experiments be-
cause under microgravity conditions, lack of sedimenta-
fig 2. Effect of substratum adhesiveness on cell shape and fre-
quency distribution of lymphocyte area. a. Lymphocytes placed
on PH2. The cells remain rounded and small, b. Lymphocytes
placed on tissue culture plastic. A considerable proportion of cells
show the typical signs of cell spreading, c. Frequency distribu-
tion of lymphocyte area. A typical analysis of an experiment is
depicted. In the uncoated control (cf fig 2b) a large portion of
spread, large cells were found. In the coated sample (cf fig 2a)
no large cells were found. These differences are significant
(table I). Bar represents 10 _.
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Table 11. Effect of substratum adhesiveness on interferon-y
production in con A activated lymphocytes. Stimulated and un-
stimulated lymphocytes were seeded on uncoated and poly-
HEMA coated plastic as indicated. Interferon-y produced by the
lymphocytes was determined in the culture supernatants follow-
ing an incubation of 72 h at 37°C.
No coating PH4 PH2 PHI
(Units/ml) (Units/ml) (Units/ml) (Units/mO
With con A Exp I 74 69 44 9
Exp 2 99 105 103 32
No con A Exp 1 2 2 0 0
Exp 2 5 2 2 1
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Fig 3. Effect of poly-HEMA coated substratum on lymphocyte
responsiveness to con A. Con A activated lymphocytes were seed-
ed on uncoated plastic (control) and plastic with increasing thick-
ness of the poly-HEMA film (PH4 to PHI). Substratum
adhesiveness decreases with increasing thickness of the poly-
HEMA layer. Following an incubation of 72 h at 37°C, lym-
phocyte proliferation was measured as the radioactivity incor-
porated into trichloroacetic acid-precipitable material. The mean
(+_ sd) of 6 experiments (ie 6 different donors) is shown. In the
control assays (no coatings) the cpm values of the incorporated
radioactivity ranged between 130 000 and 313 000 for 10 6 cells.
The incorporated radioactivity in the poly-HEMA coated dish-
es was expressed as a percentage of the corresponding control
(100%). For statistical analysis the Mann-Whitney-U-test
(2-tailed) was used (*P _< 0.01).
tion and convection could prevent cell-surface interactions
[2, 8, 9].
Our findings are similar to those reported by Folkman
and Moscona [11] using non-transformed mammalian
cells. Thus, in both non-transformed mammalian cells and
human lymphocytes, cell attachment is indispensable pri-
or to achieving optimal proliferation. Likewise, in both
studies, the magnitude of the proliferation response is
related to cell-substratum adhesiveness. The results sug-
gest that lymphocytes do not differ greatly from non-
transformed mammalian ceils with regard to attachment
and spreading. However, the present lack of data do not
allow us to conclude that with lymphocytes there is a such
close correlation between cell shape and proliferation rate
as it was found in many other non-transformed mam-
malian cells [11]. Our data are consistent with an earlier
finding that binding of lymphocytes to fibroblasts is im-
proved following stimulation [1].
The results presented here can, in part, explain data of
lymphocyte studies performed in space. In 3 independent
in vitro experiments in space we have shown that lympho-
cyte activation is depressed by 90-97% compared with 1 g
controls [2, 8, 9]. It is important to point out that nor-
mal cell-cell interactions were observed in space [8, 9]
which implies that other factors than cell-cell contacts pre-
vail in affecting lymphocyte responsiveness. However, the
depression of lymphocyte responsiveness was more
pronounced in space (90-97%) compared with even the
thickest poly-HEMA film used (68%). This indicates that
under weightlessness, cell adhesion and shape are even more
affected, or that factors other than adhesion contribute to
the reduced in vitro responsiveness. The effect of cell adhe-
sion on lymphocyte responsiveness under microgravity con-
ditions will be tested during the next Spacelab mission
(SLS-1). Cytodex microcarriers will be added to the lym-
phocyte culture to allow for adhesion in microgravity (Lee
and Cogoli, in preparation). Thus, we will determine to
what extent mitogen-induced responsiveness is restored
when lymphocytes bind to an adhesive substratum in space.
An interesting issue is the relation between the in vitro
studies addressed in this paper and the depressed lympho-
cyte responsiveness to mitogenic lectins found in ex viva
lymphocyte cultures from astronauts during and after
space flights. This finding was first reported by Soviet im-
munologists in 1973 [18], confirmed following US inves-
tigations on Skylab astronauts [17], and observed in the
majority of Space Shuttle crew members [24]. Although
such an impairment of lymphocyte function may possi-
bly lead to lowered immunity, the astronauts and cos-
monauts have maintained good health, both during and
following their flights, with the exception of minor
problems with respiratory tract infections and viral gas-
troenteritis on the Apollo flights [15] and a case of pneu-
monia on a Soviet Soyuz-Saljut mission [5]. Cogoli and
Tschopp [7] have cautioned that one should not extrapo-
late from data obtained in in vitro experiments to the
depressed ex viva lymphocyte responsiveness in astronauts
observed after space flight. It is more likely that the mul-
tiple stressors associated with space flight contribute to the
depressed immunity observed in astronauts [13, 24]. It is
conceivable that in in vitro studies lymphocytes obtained
from relaxed donors are not primed by stress-associated
hormones [13, 24, GmiJnder et al, submitted]. Thus, the
effect of space flight on lymphocyte function warrants
more detailed investigations considering the ambitious ac-
tivities planned for long-term flights on space stations and
interplanetary travels.
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Abstract
We investigated the effect of substratum adhesiveness on lym-
phocyte responsiveness by reducing and blocking cell adhesion
with poly-HEMA (poly (2-hydroxyethyl methacrylate)) In a
simple on-ground system. Cells grown on medium-thlck and
thick poly-HEMA f_ns were rounded in shape and displayed
no signs of spreading. By contrast, on tissue culture plastic and
very thin POly-HEMA films, they showed clear signs of
spreading. The mitogenic response of lymphocytes grown on
thick poly-HEMA films was reduced by up to 68% of the con-
trol (tissue culture plastic). Interferon-_ production was virtu-
aUy nil when the ceils were grown on the least adhesive sub-
stratum. These results show that activated lymphocytes need to
anchor and spread prior to achieving an optimal proliferation
response. We conclude that decreased lymphocyte adhesion
• could contribute to the depressed in v/fro lymphocyte respon-
siveness found in the microgravity conditions of space flight.
Key Words: lymphocyte, adhesion, con A, poly-HEMA,
activation, spaceflight,/anmunity
by applying increasing concentrations of poly-HEMA
(poly(2-hydroxyethyl methacrylate)) to control the extent
of cell spreading. Cells grown on the least adhesive sub-
strata were rounded in shape whereas those grown on
more adhesive substrata were more flattened (Fig. I).
No poly-HEMA:
full spreading
Thin poly-FIEMA Thick poly-HEMA
film: reduced film: no spreading
spreading
Fig. I. Effect of increasing thickness of a poly-HEMA films on cell
shape of attachment-dependent mammalian cells. With increasing
thickness, cells are more rounded in s_7_ and grm_lh raCe decreases.
Report
The in vitro responsiveness of human lymphocytes to
mitogenic lectins is remarkably reduced after spaceflight.
This finding was first reported by Soviet immunologists in
1973 (1), confirmed following U.S. investigations on
Skylab astronauts (2), and obstrved on the majority of
Space Shuttle crewmembers (3). Although such an im-
pairment of lymphocyte function may possibly lead to
lowered immunity, the astronauts and cosmonauts have
maintained good health both during and following their
flights, with the exception of minor respiratory and gas-
trointestinal problems on Apollo flights (4) and one re-
ported pneumonia on a Soyuz-Saljut mission (5).
On 2 Shuttle missions we have unequivocally
demonstrated that microgravity affects lymphocyte re-
sponsiveness in vitro. The mitogenic response to con A
was severely reduced (6-8). These observed in vitro effects
in space have been explained as being due to reduced cell-
cell contacts, and other, still unidentified factors (7, 9).
The proliferation of most cells is dependent upon at-
tachment to a substratum. Folkman and Moscona (10)
studied the _'ole of cell shape in determining growth char-
acteristics of attachment dependent mammalian cells.
They decreased the adhesiveness of tissue culture plastic
Cell growth, measured by DNA synthesis, was
highly correlated with cell shape. The flattened cells had
significantly higher growth rates than the rounded ones.
Thus cell adhesion and spreading are essential for optimal
growth of mammalian attachment dependent cells.
In vivo, a considerable proportion of lymphocytes
remains suspended in the blood and lymph. In vitro stud-
ies have shown the significance of cell-cell contacts for op-
timal antigenic or mitogenic stimulation of lymphocytes
(11, 12). Regarding lymphocyte-substratum interactions
Sundqvist and Wanger (13) reported that the cultivation
of lymphocytes on bacterial plastic petri-dlshes resulted in
a reduction of 10-50% of lymphocyte responsiveness com-
pared with lymphocytes seeded on tissue culture plastic.
Furthermore the authors (13) found that the lymphocytes
placed on bacterial plastic did not show spreading. This
finding suggests that lymphocyte adhesion and spreading
is indispensable prior to achieving an optimal
proliferation response. Therefore, in relation to the effects
of spaceflight on the functioning of human lymphocytes
in in pitro assays, it is/nteresting to know to what extent
lymphocytes must depend upon attachment to a substra-
tum and spreading before proliferation can proceed nor-
mally following antigenic stimulation and how this re-
lates, if at all, to the in vivo situation.
Recent research in the field of lymphocyte contacts
Proceedings of the FourZh European Symposium on Life Sciences Research in Space. held in Trieste, ttafy, from 28 May to I Jone "99:
(ESA SP-307. November 1990)
Las focused upon lymphocyte-cell interactions, and at
least two types have been identified as a prerequisite for
the early events of an immune response. Firstly, recirc_zlat-
ing lymphocytes leave the blood by adhering to and mi-
grating between epithelial cells in specific organs (14), in
particular lymphoid sites which has been termed lympho-
cyte homing (15). The specific cell surface structures lym-
phocytes use for this process have been called homing re-
ceptors (15). On lymphocyles, two groups of heterodimer
receptors were found that are similar to extracellular ma-
trix receptors from mammalian cells (16, 17, 18). It is as-
sumed that interactions between adhesion proteins and
receptors involved in lymphocyte-cell contacts play a vital
role in the early events of an immune response.
The in vitro experiments performed in weightless-
ness (6-8) indicate that lack of sedimentation and convec-
tion could markedly modify the mitogenic response of
lymphocytes by reducing cell-cell and/or cell-substratum
contacts (Fig. 2).
0G 1G
Stimulator Responder
cell _ cell
Stimulator _ Responder
Substratum (surface)
Fig. 2. Effect of gravity on lymphoc_e sedimentation and adhesion.
Under microgravity conditions, stimulator cells (accessory cells like
monocytes and macrophages) and lymphocytes (responders) do not
sediment (diagram on the left). It is concei_rdale that in microgravity
these cells cannot adhere, anchor and spread on the substratum. This
might affect the mitogenic responsiveness. By contrast, under norms/
gravity cells may adhere, anchor and spread on the substratum
(diagram) on the fight provided that the adhesiveness of the surface is
adequate.
Thus, the depressed lymphocyte responsiveness ob-
served in vitro under microgravity conditions could result
from changes in the lymphocyte surface milieu. It is im-
portant to realize that we observed normal cell-cell inter-
actions in lymphocyte cultures obtained after spaceflight
(7, 8). This underscores the need to continue to clarify the
effect of lymphocyte-substratum adhesion on responsive-
ness. We reduced the adhesiveness of tissue culture plas-
tic by applying increasing concentrations of POly-HEMA.
We have measured amounts of lymphocyte adhesion, and
correlated these to changes in cell area as a means to esti-
mate spreading, responsiveness, and interferon-gamma
production. These experiments are important to help to
understand earlier spaceflight results and to devise future
experiments.
The effect of increasing the thickness of the poly-
HEMA film on adhesiveness of con A activated lympho-
cytes is illustrated in Fig. 3.
The proportion of nonadhering cells (represented by
sample 1) increased with increasing thickness of the poly-
HEMA films. In the control 23% of the radioactivity was
found in sample 1, compared to 74% of the highest poly-
HEMA concentration used (PH 1). Radioactivity in sample
2 (slightly adhering cells) was highest in the wells with the
intermediate poly-HEMA dilutions (PH 2). The propor-
tion of adhering cells (represented by sample 3) increased
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Fig. 3. Control of lymphocyteadhesionby variation of subslratum
adhesiveness. Fiat bottom multidishes (Nunc) were c_ted with in-
creasing thickness of poly-HEMA films (10). Dilutions of the poly-
HEMA stock solution (6 g/i in 95% ethylalcohol) were I0 _ fPH4),
10 -2 (PH2), and 10 -I (PHI). Lymphocyles were prepared by Ficoll-
Hypaque density centri[ugation (19, 20). After labelling the lympho-
cymes with SlCr204 (2I, 22), 106 cells in I ml of medium were acti-
vated with concanavalin A (25 lag/l) and placed into the wells (in
triplicates). The cultures were incubated for 4 h at 37'_.. First, 50 ld
of the _yernatant without cells v2ere sampled to check the viability of
the lymphocytes (2I). Next, the rest of the suJx'rnatant and nonadher-
ing cells were aspirated (dishes tipped at an angle of 50") using a
pipette (sample 1), and replaced by prewarmed HBSS. After shaking
the dishes on a gyratory shaker for 15 s (220 rpm, 4 mm amplilude) to
suspend loosely bound cells, the supernatant was removed again
(sample 2). Lastly, adhering lymphocy_ were lysed with NaOH (950
Id, 2 M) (sample 3). Radioactivity in the samples were determined in
a g-counter. _ proportion of cells in the 3 samples g_s calculated by
relating the radioactivity recovered in the 3 fractions to the original
radioactivity in the total cell suspension. Each value is the mean (:t
standard deviation) from 5 independent experiments using 5 different
donors. For statistical analysis the Mann-Whitney-U-test (2-tailed)
was applied (*, P:_.005).
with increasing adhesiveness of the substratum: Almost
no cells attached in the wells coated with the thickest
polymer film (3%); 22% and 42% were recovered from the
wells with the thinner coatings, PH 2 and PH 4, respec-
tively. In the control 59% of the original radioactivity was
recovered in this fraction. Clearly, an inverse relationship
exists between the thickness of the POly-HEMA film and
lymphocyte adhesiveness.
The influence of substratum adhesiveness on the
shape of activated lymphocytes was determined by
assessing the cell area of adhering lymphocytes under a
light microscope as an index of the extent of lymphocyte
spreading (Fig. 4).
We were unable to estimate the area of lymphocytes
when using the thickest poly-HEMA layer as a substratum
(PH1) since lymphocyte adherence was so poor that too
few cells would be available for statistical analysis. By
contrast, adhesion to the thinnest film used (PH4) did not
reveal any change in cell area compared with the control
(data not shown). However, a statistically significant dif-
ference in the area of attached lymphocytes was detected
on the medium dense polymer film (PH2). A significantly
higher proportion of lymphocytes after con A addition
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Fig. 4. Effect #substratum adhesiveness on cell shape. The frequency
distribution of lymphocyte area of a typical experiment (one of of five)
is depicted. Siideflasks were coated with poly-HEMA (PH2; s. Fig. 3).
Immediately after con A activation the cell suspension (4 ml contain-
ing 4 I06 cells) was loaded into slideflas_ and incubated for 18 h at
37"C. The cells were fixed by the addition of 800 ld glutaraldehyde
(10%) for 20 rain. The fixed cells were allou_ to dry at room tem-
perature, stained with Gionsa, mounted in a light microscope (1250-
fold magnification), and photographed. The cell area of SO-lO0 lym-
phocytes [rom 4 differtnt sites was determined on a graphic tablet
(Summagraphics) connected to a Macintosh computer (Software:
MacDrafl and StatVitto) by following the lymphocyt.e contours.
was spherical and smaller in area compared with a control
after culturing for 18 hours on poly-HEMA (PH2) in 5
independent experiments.
It is interesting that no large cells (> 83 lam 2) were
observed in the poly-HEMA coated wells (Fig. 4).
By contrast in all 5 experiments the occurrence of
large lymphocytes (up to 165 lain 2) was noted in the con-
trol wells. Furthermore in the uncoated wells the main
peak of areas generally showed a shift in the distribution
of cell size which included larger lymphocytes. This was
never observed in the poly-HEMA coated wells. Likewise,
only the lymphocytes grown in the control wells showed
the typical signs of cell spreading (a broad rim of cyto-
plasm around the nucleus and filopodia). These findings
suggest that the lymphocytes cultured on poly-HEMA
could not anchor and spread. In attachment dependent
cells proliferation is related to anchorage and spreading.
We next tested the effect of reduced anchoring and
spreading on activated lymphocytes and measured prolif-
eration by the uptake of racllolabelled thymidine after 72 h
(Fig. 5).
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Fig. 5. Effect of poly-
HEMA coaled substratum
on lymphocyte responsive-
hess. After con A stimula-
tion, lymphocytes were
seeded on untreated plastic
of multidishes (control)
and on increasing polymer
film thickness (PH4, PH2,
and PH1; s. Fig. 3) and in-
cubated for 72 h_ Then the
tale of DNA synthesis was
determined by the incorpo-
ration of 3H-labelled
thymidine (20). The mean
(at s.d.) of 6 independent
experiments (6 donors) is s_',cn. For statistical analysis the Mann-
Win'they-U-test (2-tailed) u_s used (*, P:_O.O1).
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We determined that lymphocyte proliferation is in-
versely related to the thickness of the poly-HEMA film.
Lymphocyte responsiveness was reduced by up to 68% of
the control at PH1 (Fig. 5). At the lowest poly-HEMA di-
lution (PH4), lymphocyte responsiveness was unaffected.
These results are similar to those reported by Folkman
and Moscona (10) using nontransformed mammalian
cells. Thus in both nontransformed mammalian cells and
human lymphocytes the magnitude of the proliferation
response is related to cell-substratum adhesiveness.
Furthermore, in both studies, the growth rate determined
by radiolabelled thymidine uptake appears to correlate
with cell shape.
When cell-substratum interactions are reduced after
con A activation, lymphocytes cannot proliferate nor-
mally. Consequently, other lymphocyte activation events
associated, such as interferon_ production, should also be
affected.
In 2 separate experiments the production of inter-
feron-'r was greatly reduced after plating con A activated
lymphocytes on the thickest poly-HEMA coated plastic
(results not shown).
Our results obtained in vitro suggest that human pe-
ripheral blood lymphocytes are attachment dependent
ceils which need adhesion to a substratum in order to fa-
cilitate anchoring and spreading for activation events and
proliferation to proceed normally. Therefore lymphocytes
do not differ greatly from nontransformed mammalian
cells in respect to attachment and spreading. This is con-
sistent with the complex functions of lymphocytes in vi,'_o
during the early events of the immune response. In par-
ticular, the interaction of lymphocytes with the endothe-
lium lining of blood vessels is important for adhesion and
diapedesing of lymphocytes into the lymphatic tissue
(lymphocyte homing) and into sites of inflammation (23,
24). It is not surprising that resting, nonstimulated B and T
lymphocytes both bind very poorly to fibroblasts (16, 23,
24). Only activated lymphocytes express the adhesion
proteins that allow for attachment to other cells and to ex-
tracellular matrix proteins such as laminin (23).
Our Findings that lymphocytes are adhesion depen-
dent can in part explain data of lymphocyte studies per-
formed in space. In 3 independent in vitro experiments in
space we have shown that lymphocyte activation is de-
pressed by 90-97% compared with I g controls (6-8). Note
that in this paper we used exactly the same protocol as in
these previous space experiments. However, the depres-
sion of lymphocyte responsiveness was more pronounced
in space (90-97%) compared with even the thickest poly-
HEMA film used (68%). This indicates that under
weightlessness, factors other than adhesion may con-
tribute to the reduced in vitro responsiveness. For in-
stance, on ground cells still sediment and their shape may
change although the cells cannot anchor on poly-HEM.A.
To check this hypothesis we subjected iymphocytes
seeded on tissue culture plastic to increased gravity (20g)
and normal gravity as a control. It is interesting that 1)-m-
phocyte area was increased in all cells at 20g compared
with lg (Fig. 6).
In particular, the modal of the main peak showed a
significant shift towards larger cells. In addition, a higher
proportion of large cells (> 85 la.rn2) was found at 208
compared with lg. This increase of cell size at 20g resulted
in a significant increase of lymphocyte responsiveness to
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Fig. 6. Effect of increased gravity (20&} on cell shape. One typical ex-
periment of 5 is shown. After the addition of con A, the lymphacytes
were seeded on PH2 and cultured as described in the caption of Fig. 5
at lg and 20g. The frequency distn'bution eta typical eaperiment is
con A of 40%, which is consistent with eariier results (25).
Likewise, on poIy-HEMA coated plastic (PH2) at 20g, the
modal of the main peak was significantly shifted towards
larger cell sizes in all five experiments (result not shown).
No large ceils (> 85 lain 2) were observed when the cells
were seeded on poly-HEMA both at lg and 20g. Thus it is
not surprising that the mitogerdc response in cells grown
on poly-HEMA was not changed by increased gravity.
This can be interpreted that increased gravity leads to an
increase in lymphocyte proliferation when the cells are
allowed to anchor and to spread.
The experiments presented here helped us to devise
future experiments under microgravity conditions.
During the next Spacelab mission (SLS-I) we will culture
lymphocytes with Cytodex microcarriers to allow for ad-
hesion under microgravity conditions (Lee and Cogoli,
manuscript in preparation). We will determine to what
extent mitogen-induced responsiveness is restored when
lymphocytes bind to an adhesive substratum in space.
With respect to the in vivo situation, Cogoli and Tschopp
(26) have cautioned that one should not extrapolate from
data obtained in in vitro experiments to the depressed
lymphocyte responsiveness observed after spaceflight. It
is more likely that the multiple stressors associated with
spaceflight contributes to the depressed immunity ob-
served in astronauts (3, 27, 28, 29). The effect of space
flight on lymphocyte function warrants more detailed in-
vestigations considering the ambitious activities planned
for long-term flights on space stations and interplanetary
travels.
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ABSTRACT
Rats were placed in whole-body harness suspension in three configurations: antiorthostatic hypokinetic/
hypodynamic suspension (AAH) to induce headward body fluid redistribution and unload the limbs, orthostatic
hypokinetic/hypodynamic suspension (OHH) to unload the limbs without fluid redistribution, and harness
restraint (HR) to produce the restraint stress of the model without fluid redistribution or musculoskeletal
disuse. AHH and OHH suspension transiently increased interferon-',/(IFN-y) production in response to the
mitogen conconavalin A. Harness restraint alone did not affect IFN-y response. However, both suspension
modeling and harness restraint caused a transient reduction in interleukin-I (IL-I) and IL-2 responses to
mitogen. This suggests that factors associated with musculoskeletal unloading affected IFN-y responses, while
IL-I and IL-2 responses were affected by the physiological stress of restraint.
INTRODUCTION
rARIOUS IMMUNOLOGIC HANGEShave been noted in hu-
mans, animals, and cell cultures during and after space
flight._ 12)Lymphoid organ involution, _4_changes in immune
cell populations, and decreased response to colony-stimulating
factor have been seen in rats following space flightJ 8_Dimin-
ished lymphocyte blast transformation in response to mitogens
has been observed consistently in space flight crewsJ 7'L1_2_
Lymphocytes taken from humans and rats immediately after
space flight have reduced ability to produce interferons (IFNs) in
response to mitogenic challengeJ 5''_ In contrast, lymphocytes
cultured during space flights show enhanced IFN production.{l°)
The underlying mechanisms of these effects, as well as their
immunologic significance, are currently unknown.
Previous studies by investigators in our laboratory have
examined IFN and interleukin (IL) responses of rats that had
flown aboard the U.S. Space Shuttle. In these studies, lympho-
cytes harvested from rats flown in space had subnormal IFN-y
production but normal IL-3 production? 5_Ground-based sus-
pension modeling has been used in attempts to reproduce or
anticipate the immunologic effects of microgravity. Impaired
IFN-a/[3 production was seen in mice and rats in suspension
experimentsJ t3._4_Reduced IFN-a/13 production in suspended
mice has been correlated to increased susceptibility to viral
infectionJ _s_Rats and mice used in various suspension models
have also shown reduced macrophage phagocytosis? _6_de-
creased superoxide production by peritoneal macrophages, _7'
and decreased in vivo production of IFNs similar to that observed
in rats fown on the U.S. Space Shuttle. cS'H'_s_
Variations on the whole-body harness suspension model were
used to test the hypothesis that redistribution of body fluids and
musculoskeletal unloading contribute to the immunologic ef-
fects of suspension and therefore may be related to immunologic
changes during space flight. Rats were placed in whole-body
harness suspension _18,J,_configured to produce musculoskelelal
unloading and reduced limb movement (hypokinesiaJ
hypodynamia). Suspensions were conducted with rats in the
head-down position (antiorthostasis) to induce fluid shifts, or in
the level position (orthostasis). Rats were also placed in the
suspension harnesses with full weight bearing on all limbs and
without head-down tilt. This allowed examination of the contri-
bution of restraint stress to the immunologic effects of suspen-
sion. Following suspension, the in vitro immunologic responses
surveyed consisted of milogen-stimulated production of the
immunologically important cytokines IFN-y, IFN-a/[3, IL-I,
and IL-2.
_Departmentof Microbiology and Immunology, School of Medicine, University'of Louisville, Louisville, KY 4(1292:-'NASA Johnson Space
Center, Houston, TX.
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MATERIALS AND METHODS
SuspensionModeling: Male, 350-400-gram CD rats (Charles
River, Wilmington, MA) were placed in the whole-body harness
suspension modelJ ts.to_ Three different configurations of the
model were used. in the first configuration, the rats were
positioned in the harness system with 20 ° head-down tilt to
induce antiorthostasis and with their hind limbs completely
unloaded to produce hypokinesia and hypodynamia. This con-
figuration is referred to as antiorthostatic hypokinetic/
hypodynamic suspension (AHH). In the second configuration,
referred to as orthostatic hypokinetic/hypodynamic suspension
(OHH), rats of the same strain, sex, and size were placed in
suspension with their hind limbs unloaded as before but without
the head-down tilt. The third suspension configuration was used
to examine the effects of restraint in the suspension harness. Rats
were placed in suspension harnesses with no tilt and with full
loading on their limbs (harness restraint, HR). Suspensions of 1,
3, 7, or 14 days duration were carried out for each suspension
type. In each experiment, rats of the same size, sex, and strain
were maintained as controls in normal caging. Food was pro-
vided to the control rats in amounts equal to the average daily
food consumption of the suspended rats. The rats were main-
rained under National Institutes of Health (NIH/guidelines in an
AAALAC accredited facility under the supervision of a veteri-
narian.
The rats were killed by a 100 mg/kg body-weight dose of
sodium pentobarbital administered i.p. The spleen of each rat
was excised under sterile conditions and washed four times in
RPMI-1640 medium (GIBCO Laboratories, Grand Island, NY)
supplemented with 10c)[ fetal bovine serum (FBS, GIBCO) and
antibiotics. Splenocytes were harvested by teasing apart the
spleens in 5 ml of medium. The splenocytes were concentrated
by centrifugation at 200 x g for 10 rain at 4°C then suspended in
30 ml of medium. The cells were counted on a hemocytometer
and viability was assessed by trypan blue exclusion. Cell
viability was always found to be 90% or greater.
IFN-_ Production: Splenic lymphocytes from the suspended
rats I1 ml at 3 × 106 cells/roll were incubated with a final
concentration of 5 Ixg/ml concanavalin A (ConA, Sigma Chem-
ical Co., St. Louis, MO) in 24-well culture plates (Falcon 3047,
Becton Dickinson, Lincoln Park, N J). The cells were cultured
tor 48 h at 37°C and 5% CO2 .120_ Following the incubation, the.
IFN-containing supernatants were collected, centrifuged at
2(X) × g for 10 rain to remove cells, and stored at -70°C.
IFN-a/[3 Pr_Muction: Splenic lymphocyte suspensions con-
taining 3 × 10 _' cells/ml in 1 ml of RPMI-1640 were incubated
with 10 Ixg/ml polyriboinosinic/polyribocytidylic acid
[poly(l:C), Sigma] and 20 la,g/ml DEAE dextran (Pharmacia,
Piscataway, N J) in 24-well culture plates for 2 h at 37°C and 5%
CO,. Following the incubation, 1 ml of additional medium was
added to each culture and the cultures were incubated for an
additional 24 hJ2°'2_ Culture supernatants containing IFN-ot/13
were harvested by centrifugation at 200 × g to remove cells and
were stored at -70°C.
Production _'IL-I and IL-2: Splenic lymphocytes from the
suspended rats (1 ml at 3 × 10 _'celts/roll were incubated with 1
gg/ml indomethicin and 5 _g/ml ConA in 24-well culture
platesJ 22_The cells were cultured for 48 h at 37°C and 5% CO 2.
Following the incubation, the supernatants were collected,
centrifuged at 200 × g for 10 rain to remove cells, and stored
frozen at - 70°C.
IFN Assays: IFN activity in supernatants was quantified by
reduction of the cytopathic effect of Indiana strain vesicular
stomatitis virus (VSV) on mouse L929 cellsJ 23_ Serial tripling
dilutions of the sample supernatants and standards were made in
the assay medium which consisted of minimal essential medium
(MEM, GIBCO) containing 2.5% HEPES (Sigma) and 5c_
FBS, in 96-well microtiter plates (Falcon 3072). A suspension
of 1 × 10 -_cells/ml was prepared from a confluent monolayer
culture of L929 cells. Each assay well received 100 I,tl of the
L929 suspension and was then incubated for 24 h at 37°C and 5c/_
CO 2. Following the incubation, 200 plaque-forming units of
VSV in 200 _1 of assay medium was added to each well and
incubation continued for 24 h or until cytopathic effects were
observed microscopically. The plates were then drained and 50
_1 of MTT (5 mg/ml in saline) and 50 _1 of assay medium were
added to each wellJ 24) Incubation was continued for 2 h and then
100 ml of 10% SDS was added. Following overnight incubation,
the plates were scanned on a microtiter plate reader (Dynatech
MR 600, Dynatech Laboratories, Alexandria, VA) at 570 nm.
Titers were defined as the reciprocal of the supernatant dilutions
giving a 50_ increase in optical density compared to controls
receiving virus without IFN.
IL-I Assay: IL-I activity in samples was quantified by a
mouse thymocyte co-mitogenesis assay. '_2' Thymocytes were
harvested from 20- 25-gram female Swiss Webster mice
(Charles River) under sterile conditions. The mouse thymocytes
were suspended at a concentration of 2 × 10_' cells/ml in
RPMI-1640 supplemented with 5% FBS and antibiotics. Sam-
ples, standards, and controls were serially diluted two-fold in
RPMI-1640 with 5% FBS and antibiotics in 96-well microtiter
plates. ConA was added to each well at a final concentration of
2 p,g/ml. Each well then received 100 I,tl of the thymocyte cell
suspension. The cultures were incubated for 72 h at 37°C and 5%
CO 2. IL- 1 induced blast transformation of the thymocytes and
quantified colorimetrically with MTTJ 24_ Following the 72-h
incubation, 20 p,l of a 5-mg/ml MTT solution was added to each
well and allowed to incubate for 4 h as before. Each well then
received 50 ILl of 10% SDS with overnight incubation. The
optical density of each well was read on a scanning microtiter
plate reader at 570 nm Titers were defined as the reciprocal of
the dilution giving a 50% reduction in optical density compared
to the highest standard.
IL-2 Assay. Stimulation of mouse splenoblast proliferation
was used to assay IL-2 activity in samples from the suspended
rats. c'-sJ Splenocytes were sterilely harvested from 20 to 25-
gram female Swiss Webster mice. The cells were suspended in
150-ml culture flasks IFalcon) at a concentration of 2 x 105
cells/ml in RPMI-1640 containing 10% FBS, antibiotics, and 5
_g/ml ConA. The cells were incubated for 72 h at 37°C and 5%
CO 2 to allow blast transformation. Following the incubation, the
splenoblasts were washed three times, resuspended at 2 × l0 s
viable cells/ml in medium, and incubated for 24 h. Serial
SIMULATEDMICROGRAVITYANDCYTOKINES
doublingdilutionsofeachsample,standards,andcontrolswere
madeinmediumin96-wellmicrotiterplates.Splenoblastswere
addedtoeachwell(50txlataconcentrationof2× 106cells/ml)
andincubatedfor20h.Followingthisincubation,20ILlof5
mg/mlMTTwasaddedtoeachwellandincubatedfor4h. 124_
The plates were scanned at 570 nm on a microtiter plate reader
following overnight solubilization of the reaction products with
100 i,zl of 10% SDS. Titers were defined as the reciprocal of the
dilution giving a 50% reduction in optical density.
Statistical Analysis: Student's t-test was used to establish the
statistical significance of differences between results for exper-
imental and control samples. Alpha was set a priori at p_<O.05.
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RESULTS
Body weight
Rats placed in suspension or harness restraint lost consider-
able body weight as did their pair-fed controls. The weight loss
in suspended and restrained groups was nearly identical. Sus-
pended rats initially lost weight at a faster rate than their pair-fed
controls. However, by 14 days of suspension, total weight loss
was the same in the controls and suspended animals.
1FN-edf3 production
Lymphocytes from AHH suspended rats tended to produce
less IFN-a/[?, activity than those from controls through day 7 of
suspension; however, the numerical differences did not reach
statistical significance. Cells from rats in the OHH configuration
produced similar results with a significant depression of IFN-
a/13 production occurring at day 3 (Fig. 1). IFN-cdl3 production
in HR suspended rats was similar to that of the AHH rats, with
the exception that a significant depression of interferon produc-
tion occurred at 7 days.
IFN-'y production
IFN-_ production by the lymphocytes of suspended rats was
significantly increased at day 3 by both the AHH and OHH
suspensions (Fig. 2). Afterwards, IFN titers were equivalent to
controls in the AHH animals but were significantly enhanced at
day 14 in the OHH rats.
IL-1 production
Lymphocytes from rats experiencing both head-down tilt and
musculoskeletal unloading in the AHH suspension configura-
tion produced significantly less IL-I compared to controls
following 1 or 3 days of suspension (Fig. 3). Production of IL-1
was normal at 7 or 14 days of suspension• Rats experiencing
musculoskeletal unloading without head-down tilt (OHH)
showed a similar trend in IL-1 production: however, the depres-
sion of IL-1 production was significant only on day 3• Harness
restraint suppressed IL-1 production at days I and 7.
IL-2 production
All three of the suspension configurations transiently de-
pressed IL-2 production by lymphocytes from suspended rats
120
100
80
60
40
20
0
B.
1 3 7 14
C
120
100
80 ¸
60 "
40
2o -"
o"
1 3 7 14
DAYS IN SUSPENSION
FIG. 1. Effects of suspension modeling on rat IFN-a/[?,
production. Rats were placed in one of three harness suspension
configurations to simulate the unloading and fluid redistribution
of microgravity. Following suspension, splenocytes from sus-
pended and control rats were stimulated with poly(I:C) and their
IFN-a/[3 response was measured. A. Results for rats in AHH
(hind limbs unloaded, 20 ° head down tilt). B. Results for rats in
OHH (hind limbs unloaded, no tilt). C. Results for rats in HR
(harness restraint). Each bar represents the mean titer -+ SE of
two separate experiments with 5 rats/experiment. *p <_ 0.05.
(Fig, 4), IL-2 production appeared to be depressed at 1 and 3
days of suspension regardless of the suspension type, with
statistically significant depression occurring at 3 days of suspen-
sion in the AHH and OHH rats, and at 1 and 3 days in the HR
rats,
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FIG. 2. Effects of suspension modeling on rat 1FN-'y produc-
tion. Rats were placed in one of three harness suspension
configurations to simulate the unloading and fluid redistribution
of microgravity. Following suspension, splenocytes from sus-
pended and control rats were stimulated with ConA and their
IFN-7 response was measured. A. Results for rats in AHH (hind
limbs unloaded, 20 ° head down tilt). B. Results for rats in OHH
(hind limbs unloaded, no tilt). C. Results for rats in HR (harness
restraint). Each bar represents the mean titer -+ SE of two
separate experiments with 5 rats/experiment. *p _<0.05.
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FIG. 3. Effects of suspension modeling on rat IL-I produc-
tion, Rats were placed in one of three harness suspension
configurations to simulate the unloading and fluid redistribution
of microgravity. Following suspension, splenocytes from sus-
pended and control rats were stimulated with ConA and their
IL-1 response was measured. A. Results for rats in AHH (hind
limbs unloaded, 20°hcad down tilt). B. Results for rats in OHH
(hind limbs unloaded, no tilt). C, Results for rats in HR (harness
restraint). Each bar represents the mean titer -+ SE of two
separate experiments with 5 rats/experiment. *p <_ 0.05.
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FIG. 4. Effects of suspension modeling on rat IL-2 produc-
tion. Rats were placed in one of three harness suspension
configurations to simulate the unloading and fluid redistribution
of microgravity. Following suspension, splenocytes from sus-
pended and control rats were stimulated with ConA and their
IL-2 response was measured. A. Results for rats in AHH (hind
limbs unloaded, 20° head down tilt). B. Results for rats in OHH
(hind limbs unloaded, no tilt). C. Results for rats in HR (harness
restraint). Each bar represents the mean titer --- SE of two
separate experiments with 5 rats/experiment. *p _< 0.05.
DISCUSSION
Microgravity or "weightlessness" in space flight is character-
ized by the absence or reduction of various biologically relevant
forces. Mechanical loading, hydrostatic pressure, thermal buoy-
ancy, and sedimentation are absent or greatly reduced in micro-
gravity. The absence of these forces may directly affect cellular
activity or indirect effects .may result as a consequence of
physiologic responses to microgravity.
Reduced loading in microgravity results in loss of muscle
mass _26_and reduced bone growth or loss of bone massJ 27 _9_
Body fluids, which tend to pool in the lower extremities under
normal gravity, are redistributed to the upper body _3°)during
exposure to microgravity. The physiologic mechanisms control-
ling fluid balance, bone and mineral homeostasis, and muscle
metabolism are known to integrate with the immune system
through cytokines, hormones, neurotransmitters, and
neuropeptidesJ 3_'32_This raises the possibility that systemic
endocrine changes due to fluid redistribution, musculoskeletal
deconditioning, and stress contribute to the known or suspected
immunologic effects of spaceflight.
Rodent suspension experiments model body fluid redistribu-
tion and musculoskeletal effects approximating those of space
flight. Suspension modeling has been used as well to model and
predict the immunologic effects of microgravity. In this study,
suspension modeling was used to expand on previous studies of
cytokine responses during suspension and to begin exploration
of mechanisms of immunologic change during space flight.
The results of this study can be summarized as follows: (i)
Suspension with or without head-down tilt transiently sup-
pressed lymphocyte production of IL-I and IL-2. IFN-a/13
responses of lymphocytes from suspended rats tended to be
suppressed during the first few days of suspension while IFN-_
responses were transiently enhanced; (ii) Simple restraint of rats
in the suspension harness, with full load bearing on the forelimbs
and hindlimbs, produced immunologic effects similar to those of
musculoskeletal unloading regardless of head-down tilt.
The finding that restraint in the suspension harness produced
immunologic effects essentially identical to those of suspension,
regardless of head-down tilt, suggests that most of the immuno-
logic effects are related to restraint rather than hypokinesia/
hypodynamia or antiorthostasis. Restraint is a potent elicitor of
the physiologic stress response, which is well known to suppress
immunologic functionsJ TM However, restraint of rats in the
suspension harness, even with full loading on the limbs, entailed
some reduction of limb movement. Therefore, it is possible that
hypokinesia contributed to the effects of harness restraint as well
as to those of suspension.
A previous study found that AHH suspension reduced the
ability of mice to produce IFN-a/13 but that mice suspended in
the OHH position retained that abilityJ jS_ In contrast to the
previous study using mice, these results indicate that suspension
modeling has little, if any effect on in vitro IFN-a/13 production
in rats regardless of body orientation or loading. This may
indicate that the mouse model is more appropriate for studying
the immunologic effects of body fluid redistribution in suspen-
sion modeling.
Reduced in vitro IFN-_, production has been seen in humans
and rats lollowing space flight. _5"9m_In this suspension study,
IFN-'y production was increased following suspension. How-
ever, the increase in IFN production was seen only in rats which
experienced musculoskeletal unloading. Therefore, factors as-
sociated with musculoskeletal unloading appear to be responsi-
ble for the effects on IFN-'y. Considering the similarity between
the musculoskeletal effects of suspension modeling and micro-
gravity, then similar IFN-'y effects would be expected to occur in
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space flight. However, increased IFN--y production in AHH and
OHH rats in this study contrasted with space flight results, which
found that in vitro IFN-'y production was lower in rats following
space flight/5_ Cells from the space flight rats were harvested
after reentry and landing, and had to be transported at 1 gram for
several hours, therefore, the effects seen in the flight study may
have reflected readaptation to gravity following space flight
rather than the effects of microgravity proper.
Comparisons of the effects of suspension on IL production
with those of space flight are impossible at present since
measurements of these responses have not been reported in
humans or other animals during or following space flight.
Suppression of the IL- 1 and IL-2 response in the restrained rats
as well as the suspended rats is consistent with stress-induced
• (=14)immunosuppresston. -
It has been pointed out that IL-2 usually correlates with IFN-'y
in cultures of ConA-stimulated lymphocytes. Reduced 1L activ-
ity coinciding with increased IFN-_/activity in AHH and OHH
suspended rats may represent an uncoupling of cytokine regula-
tory pathways.
The results of these studies show that rat suspension modeling
of microgravity can induce functional changes in cellular immu-
nity in vitro. Body fluid redistribution and musculoskeletal
unloading do not appear to contribute to the observed immuno-
logic changes with the exception of the increased in vitro IFN-'y
response, which was apparently related to musculoskeletal
unloading. The immunologic effects were otherwise consistent
with immunosuppression related to the physiologic stress of
restraint.
Assuming that activation of physiologic stress in the suspen-
sion mc, del is comparable to that of actual space flight, then
similar transient immunologic effects should occur in short-term
flights. However, these findings do not rule out possible immu-
nologic consequences of fluid redistribution and musculoskele-
tal deconditioning during long-term space flights. Experiments
conducted in vivo during space flights will be necessary to
answer these questions.
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ABSTRACT
Changes in resistance to bacterial and
viral infections in Apollo crew members has
stimulated interest in the study of immunity and
space flight. Results of studies from several
laboratories in both humans and rodents have
indicated alterations after space flight that
include the following immunological parameters:
thymus size, lymphocyte blastogenesis, interfer-
on and interleukin production, natural killer
cell activity, cytotoxic T-cell activity, leuko-
cyte subset population distribution, response of
bone marrow cells to colony stimulating factors,
and delayed hypersensitivity skin test reactiv-
ity. The interactions of the immune system with
other physiological systems, including muscle,
bone, and the nervous system, may play a major
role in the development of these immunological
parameters during and after flight. There may
also be direct effects of space flight on
immune responses.
INTRODUCTION
Until recently, reports on the effects of
space flight on the immune system have been
interesting, but often inconclusive (I-5).*
These studies have been limited by small sample
size, the relatively small number of flights
available for immunological studies, and,
occasionally, by uncontrollable experimental
conditions (1-5). Nevertheless, it is
apparent from the results of these earlier
studies that some alterations of immunological
parameters do occur during, or immediately
following, space flight. Several factors could
contribute to these effects, including micro-
gravity, stress, radiation, and interaction
with other host biological systems. This
*Numbers in parentheses designate references at
end of paper.
report reviews our current understanding of the
effects of space flight, and of systems used to
simulate the effects of microgravity, on immune
responses.
MICROGRAVITY MODELING SYSTEMS
As a result of the limited opportunities
for space flight, ground models simulating some
aspects of space flight have been used to study
changes in immune responses. Immune responses
of rodents have been the main subject of these
studies, because modeling using these quadrupeds
was more easily and economically carried out.
In one such study, mice were maintained in
a "space cabin" environment in which barometric
pressure was altered in a pressure chamber (6).
These confined mice were more susceptible to
mengovirus infection than were control mice.
These data suggested that maintenance of mice
in this restricted environment with alterations
in pressure could have resulted in alterations
in immune responses, such as interferon or anti-
body production, that decreased their resistance
to viral infections.
By far the most widely used model to sim-
ulate some aspects of weightlessness that occur
during space flight has been antiorthostatic,
(15-20 o head-down tilt), hypokinetic, hypodynam-
ic suspension (no load on the hind-limbs) by
tail (7) or by harness (8). The immunologic
results have been obtained using either rats or
mice suspended similarly (9). The suspension
model promotes the development of physiological
changes in muscle, bone, fluid-shifts, and
certain other parameters that simulate changes
observed following flight (7,8). For example,
suspended rats showed involution of the thymus
similar to that seen after space flight (10,11).
Although rodent suspension is a less than perfect
model for simulating the phsyiological effects
of microgravity seen during space flight, it has
proven useful in aiding the determination of
which immunological parameters should be studied
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in rare flight experiments.
One set of experiments involved the study
of cytokines. Cytokines are soluble, non-anti-
body mediators that play a major role in cell-
to-cell communication and regulation of immune
responses (12). The major cytokines studied
were the interferons. Interferons are a family
of proteins that have antiviral activity and
several other activities, including regulation
of immune responses (12). Interferon-alpha is
produced by leukocytes primarily after stimula-
tion with viruses, double-stranded RNAs, or other
non-specific inducers (12). Interferon-beta
production, primarily by fibroblasts, is init-
iated by the same stimuli as is interferon-alpha
(12). In many cases, these two interferons are
difficult to separate and are referred to common-
ly as interferon-alpha/beta. The third type of
interferon, interferon-gamma is a product of
T-lymphocyte-mediated responses stimulated either
with a specific antigen or with a mitogen such
as concanavalin-A (12).
The first cytokine studies showed that
suspension of rats in an antiorthostatic model
resulted in severe inhibition of interferon-
alpha/beta production (13). The rats were sus-
pended antiorthostatically in this tail suspen-
sion model for two weeks,and then challenged
intavenously with polyriboinosinic-polyribocyt-
idylic acid (poly-I.C, a double-stranded RNA
inducer of interferon-alpha/beta). There was
an 80% decrease in interferon-alpha/beta produc-
tion compared to normally caged controls (13).
In more recent studies, rats were suspended
antiorthostatically for I-2 weeks, and spleens
were removed immediately after the rats were
taken down from suspension. Spleen cells were
placed in culture and then challenged with either
poly-I.C or concanavalin-A, Both interferon-
alpha/beta and interferon-gamma production was
altered (14). These results suggest that anti-
orthostatic suspension of rats resulted in
altered interferon production, a finding
similar to that observed when cosmonauts were
tested for interferon production after space
flight (15).
Similar results were observed when mice
were suspended antiorthostatically (16). In
an attempt to control for the stresses of
confinement and suspension, mice were also sus-
pended orthostatically in a harness with no head-
down tilt. Mice suspended I-2 weeks in the
antiorthostatic orientation showed severely
inhibited interferon-alpha/beta production com-
pared to controls housed normally (16). Mice
suspended in the orthostatic orientation showed
no change in interferon-alpha/beta production
compared to controls (16). This suggested that
the antiorthostatic orientation of suspension
was required for inhibited interferon-alpha/beta
production, i.e. the stress of suspension alone
could not account for inhibited interferon pro-
duction. Mice suspended antiorthostatically
and then allowed to recover in normal cages for
one week regained their capacity to produce
interferon-alpha/beta (16).
In addition, suspended mice were inoculated
with the D variant of encephalomyocarditis virus
(EMC-D virus). EMC-D virus is a convenient
virus to work with, because alteration in a
glucose tolerance test is all that is necessary
to show successful infection with the virus.
Females of the Swiss/Webster strain of mouse
normally are totally resistant to infection
with EMC-D virus (17). Resistance to EMC-D
virus is mediated, at least in part, by inter-
feron (17). Antiorthostatically suspended mice
became susceptible to infection, while ortho-
statically suspended mice remained resistant
to infection (17). Alterations in resistance to
EMC-D virus correlated with alterations in
interferon production. These results indicated
that changes in immunological parameters induced
by antiorthostatic suspension had the potential
to alter resistance to infection.
Other mouse suspension studies have shown
that leukocytes from mice suspended antiortho-
statically had impaired ability to produce
superoxide, decreased ability to kill phagocy-
tosed bacteria (Propionibacterium acnes) and
had altered serum corticosterone levels (18).
This indicated that antiorthostatic suspension
could alter the inflammatory and phagocytic
responses.
The suspension studies described above
indicate that this model of some aspects of
microgravity resulted in alterations of important
immunological parameters. The resulting
information has provided a basis for planning
space flight studies.
IMMUNOLOGICAL STUDIES INVOLVING THE INTACT
ORGANISM
Although cellular immune responses of U.S.
_nd Soviet crew members have been studied by
various methods for two decades, their remains
a limited pool of reliable information from
which to draw conclusions. Considerable immuno-
logical testing was performed following 11 U.S.
Apollo flights, 3 U.S. Skylab flights, and
U.S./U.S.S.R. Apollo-Soyuz flights (19). In
addition, postflight alterations in the in vitro
responses of cosmonaut lymphocytes were reported
following the flights of Soyuz 6, 7, 8, and 9
(20); for the two Soyuz visits to the Salyut 4
space station, Soyuz 24, 26 and 27; Salut 5;
and the two Soyuz visits to Salyut 6 (21).
However, because of small sample sizes, mission
anomalies and constraints on analytical condit-
ions, the resulting data were generally incon-
clusive (19). Nevertheless, a pattern seemed
to be developing. These studies appeared to
suggest that lymphocyte activity may be depressed
following spaceflight and that a postflight
leukocytosis concurrent with a postflight lympho-
cytopenia could be exprected (19).
Extensive comparisons of preflight and post-
flight immunological parameters were conducted
with the first 41 U.S. Space Shuttle astronauts
(4,5). This study demonstrated unequivocally
that the absolute number of lymphocytes in the
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peripheral circulation, the ability of these
cells to respond to mitogenic stimulation
(lymphocyte blastogenesis), and the number of
eosinophils in the peripheral circulation were
all decreased typically after flight. Converse-
ly, there was an almost universal doubling of the
absolute neutrophil number, and often a major
change in the CD_/CD8 (helper T-cell/cytotoxic-
suppressor T-cell) ratio. This latter event
resulted from an increase in the helper (CD4)
T-lymphocyte population as determined by flow
cytometric analysis (5). Data from Space
Shuttle flights 41B and 41D involving 11 crew
members indicated a postflight decrease in
circulating monocytes and B-lymphocytes.
Further, the reduced T-lymphocyte blastogenesis
was shown to correlate with monocyte count.
Since monocytes serve a critical role during
lymphocyte activation for blastogenesis as potent
immunoregulatory cells through release of
cytokines, these findings suggested a possible
mechanism for blunted i__nyitro mitogen-induced
blastogenesis (19).
Only recently has the effect of space
flight on the ability of the human cell-mediated
immune system to function normally in vivo been
tested in flight. This was accomplished by
using the delayed-type hypersensitivity (DTH)
response to recall antigens as a simple, yet
effective method for evaluating in-flight
mediated abnormally diminished reactivity in
U.S. Space Shuttle crewmembers. The cell-mediat-
ed immune mechanism was evaluated in 10 astro-
nauts by measuring their in-flight DTH response
to the common recall antigens of tetanus, diph-
theria, tuberculin, Streptococcus, Proteus,
Candida, and Trichophyton. Three of the subjects
were evaluated after four days, three after five
days, and four after ten days of space flight.
The mean number of reactions within the popula-
tion of 10 subjects was reduced from 4.5 pre-
flight to 3.0 during flight, and the mean
aggregate reaction size decreased from 21.4 mm
before flight to 13.7 mm during flight. The
authors reported that the data suggest that on
day 4 of a Space Shuttle mission, the cell-
mediated immune system is degraded measurably.
Between day 5 and day 10, the depression reaches
its maximum, and the cell-mediated immunity
mechanism begins to adjust to the new conditions
(Taylor, G.T., e_t_ta l., presented at the 1990
American Society for Gravitational and Space
Biology Meeting, Louisville, KY).
Soviet/Hungarian studies have also indicated
that leukocytes from some cosmonauts had a severe
decrease in production of interferon-alpha/beta
immediately after return from flight (15).
Additional Soviet studies have indicated drama-
tic decreases in natural killer and cytotoxic
T-lymphocyte activity in the peripheral blood of
cosmonauts obtained within 24 hours following
space flight.
Studies with the human antibody-mediated
humoral immune system have been more limited
and inconclusive. These studies have shown
that there did not appear to be alterations in
the circulating levels of immunoglobulin classes
in astronauts after flight in a Space Shuttle
mission (22). There have been no studies to
date to determine the effects of space flight
on the ability to sensitize a host to specific
antigen during flight, or the ability of a host
to develop an immune response during flight
after being sensitized on the ground. Therefore,
the effects of space flight on antibody responses
remain largely unexplored.
Additional flight studies have been carried
out using rats. Several studies of rats flown
in space have indicated that prolonged space
flight resulted in hypoplasia of lymphoid organs
and alterations in mitogen-induced blastogenesis
(2,3). These effects were transient, and re-
turned to normal after a postflight recovery
period (2,3).
Several rats were flown in SpaceLab-3, and
experiments were carried out to determine the
effects of flight on cytokine production (23).
The rats were flown on the Space Shuttle for 7
days, and after landing, a transcontinental
airplane flight and a 12 hour delay occured prior
to sacrifice (23). This delay _ airplane flight
could have affected the results of the study.
After sacrifice, spleens were removed from the
rats and placed in individual cell cultures.
The cultures were then challenged with concanav-
alin-A to induce cytokines. After the appropri-
ate time interval, culture supernatant fluids
were harvested and assayed for interferon-gamma
activity. Interferon-gamma production was
reduced significantly in cells taken from rats
flown in space, compared to cells from control
rats (23). This flight experiment yielded
results consistent to those observed after anti-
orthostatic suspension of rats, and with the
results of impaired interferon production by
cosmonauts after flight (15).
Production of another cytokine, interleukin-
3, was also measured in the same SpaceLab-3
experiment (23). Interleukin-3 plays a major
role as a growth factor for immunologically
important cells. In this case, spleen cells
from rats flown on SpaceLab-3 showed the same
pattern of production of interleukin-3 as did
cells from control rats (23). These data
suggested that not all immunological parameters
are affected by space flight.
Additional studies were carried out aboard
the Cosmos # 1887 Soviet space flight. In this
flight, the immunological studies were extended
to additional areas. Experiments were carried
out to determine the effects of space flight on
the distribution of leukocyte subpopulations.
The distribution of leukocyte subpopulations has
been shown to be an important indicator of
normal immunological function: for example,
patients with acquired immune deficiency syndrome
(AIDS) have an altered ratio of helper T-lympho-
cytes to suppressor T-lymphocytes (25). In the
first set of experiments, spleens were removed
from 5 rats flown for 12 and one-half days on
biosputnik Cosmos # 1887. The biosputnik landed
off-course, and a 48 hour delay and a trans-
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continental airplane flight occured between
landing of the space capsule and sacrifice of
the rats, which may have affected the results
observed. The spleens were dissociated into
individual cells and separate samples were
stained with different antibodies directed
against cell surface markers. These antibodies
were: anti-asialo GM-I (natural killer cells),
0X-39 (interleukin-2 receptor),OX-1 (pan-
leukocyte marker), W3/25 (helper T-lymphocyte),
OX-8 (suppressor/cytotoxic T-lymphocyte), W3/13
(pan T-lymphocyte), OX-4 (polymorphic la-class II
histocompatibility antigen), anti-rat IgG Fab',
anti-rabbit IgG (irrelevant antibody control),
and no antibody (negative control). The stained
cells were analyzed by flow cytometry. Although
there may have been problems with nonspecific
staining, the authors reported a trend suggesting
a dramatic shift in some cell populations
compared to synchronous controls (rats housed
and treated in a similar fashion to flight
animals with the exception of microgravity and
radiation exposure of flight) and ground
controls (vivarium controls in standard vivarium
housing). These dramatic shifts were noted in
populations of total T-lymphocytes, helper T-
lymphocytes, suppressor/cytotoxic T-lymphocytes
and interleukin-2 receptor bearing T-lymphocytes
(24).
Additional studies carried out onrats
flown in Cosmos # 1887 involved bone marrow
cells. Due to the limited number of bone marrow
cells from the femur available for the experi-
ment, the distribution of only two cell popula-
tions was examined in the bone marrow, i.e. the
total leukocyte population and the leukocytes
carrying surface immunoglobulin. The analysis
showed a larger number of myelogenous cells
bearing surface immunoglobulin from flown rats
as compared to synchronous and ground control
rats (24). Myelogenous cells are monocyte/
macrophage precursors and would not have been
expected to have a surface immunoglobulin
marker. In addition, the bone marrow cells
were tested for their ability to respond to
colony stimulating factor-monocyte (CSF-M).
CSF-M stimulates the division of monocyte/
macrophage precursors (26). The bone marrow
cells were from flown rats were inhibited in
their ability to form colonies in the presence
of CSF-M, indicating a lack of division, and
possibly maturation, on the part of the
precursor cells (24). The bone marrow cell data
suggested that an unusual response for
myelogenous cells (i.e. possibly aberrent
division and bearing of the inappropriate
surface immunoglobulin marker) was induced by
space flight, and those cells were refractory
to additional exogenous stimulation by CSF-M
upon return to earth. Monocytes/macrophages,
therefore, are immunologically important cells
that appear to be affected by space flight.
Additional Soviet studies carried out on
Cosmos biosputnik flights have indicated that
space flight resulted in decreased rat natural
killer cell and cytotoxic T-lymphocyte activity
(27). Therefore, rodent studies confirm and
extend the human studies that suggest that space
flight results in severe alterations of immune
responses.
IMMUNOLOGIC STUDIES INVOLVING CELL CULTURES
The studies described above indicate that
certain immunological functions in animals and
humans appear to be affected by space flight.
Several studies have been carried out to deter-
mine the ability of isolated cells to sense and
respond to changes in the gravity vector.
Cogoli and his associates (28-30) developed an
incubator that allowed them to carry out
lymphocyte culture experiments during space
flight. In this case, human lymphocyte cultures
were exposed to mitogens during space flight.
Lymphocyte blastogenesis was inhibited signif-
icantly compared to ground controls (28-30).
Similar results were obtained when lymphocytes
were maintained in a clinostat on the ground
(31). A clinostat is a centrifuge-like device
that randomly changes the direction of the
gravity vector (31).
In a follow-up experiment, cells were also
incubated during flight in a centrifuge that
subjected the cells to i G. Much of the blasto-
genic capacity of the cells was regained (28-30).
This could indicate a direct effect of gravity
on the cellular processes, or perhaps some
abnormal cell-to-cell contact in microgravity.
An additional explanation could be that the"
lack of blastogenesis was due to an impairment
of the ability of receptors on the cells to
interact withmitogen. Later studies using
altered substrata for the cells on the ground
indicated that decreased lymphocyte adhesion
could contribute to the suppressed in vitro
lymphocyte blastogenesis observed during space
flight (32). In any case, the results of this
series of experiments indicated that a cellular
immune process was inhibited in isolated cells
during space flight.
An additional study using cultures of human
leukocytes was carried out by Talas and her
associates (15). Various mitogens and inducers
were added to the cultures to induce interferon-
alpha/beta. The cells from the cultures
produced strikingly higher levels of interferon-
alpha/beta than did cells from control cultures
maintained on the ground (15); however, it should
be noted that this was a limited experiment with
a small "n". This result was different from that
observed from the cosmonauts after the same
flight, and different than the results of the
rodent studies in which interferon-alpha/beta
production was inhibited.
It is not surprising that results differed
between the cell culture studies and the studies
of cells from intact organisms flown in space.
In the latter case, the immunologically important
cells may interact with other cells and other
systems. In the host, the cell is in its natural
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milieu, able to interact and cooperate with
other cells and other systems. For example,
the immune system interacts closely with the
neuroendocrine system (33). The interactions
of the immune system with other systems in
space flight certainly require additional study.
CONCLUSIONS
It is apparent from the studies described
above that space flight has profound effects on
immune responses. The mechanisms of these
effects remain to be established. Although
cell culture studies and ground-based modeling
have suggested that both microgravity and stress
can play some role in the alterations of the
immune response observed after space flight, the
full nature of that role remains to be estab-
lished. In addition, the role of radiation and
other space flight factors has not been studied
to a great extent.
In addition, it is clear that the full
range and duration of the effects of space
flight on the immune response have not been
established. The effects of long-term flight as
opposed to short-term flight remain to be
established. The duration and reversibility of
the effects of space flight on immune responses,
particularly after long-term flights, has not
yet been established.
Most importantly, the effects of space
flight-induced immune alterations on resistance
to infection has not been demonstrated. This
could have profound effects on the ability to
carry out long-term manned space flights. In
addition, if resistance to infection is altered,
the development of possible countermeasures
should be undertaken.
In short, it is now clear that space flight
affects immune responses. Much work remains to
be done to establish the significance of these
effects.
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